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Fungi are neither plants nor animals, they are considered to constitute the third large kingdom 
of organisms. Their characteristic features set them uniquely apart from plants and animals
1
. 
Mushroom is the fruit body of a fungus, the reproductive part which grows either above or 
below ground and release spores, the seed-like elements from which new fungi are made
2
. 
Mushrooms have widely been appreciated by humans for their nutritional and health benefits. 
Fresh and preserved mushrooms are consumed as a delicacy, particularly for their aroma and 
texture, but also for their low calorie level and high fiber content
3
. A plenty of studies have 
reported that mushrooms produce a broad range of high- and low-molecular weight primary 





















Inflammation is a biological response to injury, characterized by loss of function and 
pain, heat, redness and swelling. It is usually linked with the pathogenesis of diseases such as 
diabetes, arthritis, obesity, metabolic syndrome, cancer and several cardiovascular diseases
24
. 
Macrophages play a key role for regulation of inflammatory responses. Activated 
macrophages release a variety of inflammatory mediators, including tumor necrosis factor-α 




Atrial fibrillation (AF) is the most common arrhythmia affecting patients today. 
Disease prevalence is increasing at an alarming rate worldwide, and is associated with often 
catastrophic and costly consequences, including heart failure, syncope, dementia, and 
stroke
26
. In Europe and North America, 2 to 3% of the population had been diagnosed as AF 
in 2014. In addition, AF occurs more frequently in males and elder people
27
. Even though the 
underlying mechanisms of AF is not yet entirely understood, the cardiac acetylcholine-
activated potassium ion channel (IKACh) is considered a novel and attractive target for drug 
therapy in the treatment of AF
28
. This ion channel is member of the G-protein coupled 
inwardly rectifying potassium channel (GIRK) superfamily and is composed of GIRK1/4 
(Kir3.1 and Kir3.4) subunits
29
. It has been described that GIRK1/4 is constitutively active in 
myocytes from patients with chronic AF or from dog model of atrial tachycardia, and, 
furthermore, these studies have demonstrated spontaneous openings of these channels in 
myocytes from chronic AF patients
28, 30, 31
. Taking all these findings together, constitutively 
active GIRK channels in the atrium elevate proarrhythmic risk by causing dispersion of atrial 
2 
 
repolarization and refractoriness, therefore, a selective GIRK blocker without affecting 




In the last decades, mushrooms were brought increased attention due to their 
secondary metabolites with high structural diversity. This can be exemplified by the rotary 
door-shaped meroterpenoid lingzhiols from Ganoderma lucidum
34
, highly rearranged 
triterpenes, spiroinonotsuoxotriols from Inonotus obliquus
35
, the macrocyclic diterpenoid 
eryngiolide A with cyclododecane skeleton produced by Pleurotus eryngii
36
 and cyclic 
octadecapeptides from Gymnopus fusipes
37
 among others. However, the medicinal potential 
of mushrooms has not been fully investigated. Additional biological studies are needed to 
confirm the pharmacological properties or side effects of mushroom extracts and their 
metabolites. 
The current thesis summarizes the chemical and pharmacological experiments 
performed on Hypholoma lateritium providing a detailed pharmacological and toxicological 
evaluation of metabolites of Hypholoma lateritium in order to identify new natural products 
of promising potential in the treatment of inflammation and atrial fibrillation. 
2 AIMS OF THE STUDY 
In the last years the research group of the Department of Pharmacognosy at the University of 
Szeged started a screening program to investigate the pharmacological activities of 
Hungarian fungi and to identify the bioactive compounds of the selected mushrooms. The 
aim of the present work as part of this project was the identification of biologically active 
compounds from Hypholoma lateritium and characterization of their chemical, 
pharmacological and toxicological profiles. 
In order to achieve the aims, the following tasks were carried out: 
 A review of the literature of the Hypholoma lateritium, from aspects of the chemistry 
and pharmacological properties of the fungi. 
 Extraction of Hypholoma lateritium with various organic solvents (n-hexane, 
chloroform and 50% methanol) and with water for screening.  
 Collection and extraction the mushroom material of Hypholoma lateritium for 
preparative work. 
 Isolation the bioactive compounds responsible for the observed ion channel and anti-




 Elucidation the structures of the isolated compounds by NMR and MS methods (in 
collaboration with Gedeon Richter Plc., Hungary), providing characteristic spectral 
data on the isolated new metabolites. 
 In vivo toxicological evaluation of compounds from Hypholoma lateritium using 
bdelloid rotifer assays. 
 Investigation of the activity of compounds from Hypholoma lateritium on GIRK and 
hERG channels. 




3 LITERATURE REVIEW 
 
3.1 Morphology of Hypholoma lateritium 
The genus Hypholoma, which means “mushrooms with threads”, belongs to the family 
Strophariaceae, and includes mushroom species characterized by the presence of well-
pigmented pileus and variably developed thread-like veil, which does not form a 
membranous annulus on the stipe
38
. The genus comprises about 30 species worldwide, 
distributed from temperate to tropical regions, growing on decomposing wood, living trees, 
or soil
39
. Hypholoma species are recognized as active wood and litter decomposers, and play 
a significant role in forest ecosystems, being used not only in bioconversion of cellulose, 
fabric and dye industrial residues
40, 41
, but also in biological control of phytopathogenic 
fungi
42, 43
. Hypholoma lateritium ((Huds.:Fr.) P.Kumm. (syn. Hypholoma sublateritium (Fr.) 
Quél. and Naematoloma sublateritium (Fr.) P. Karst.)) – commonly known as brick cap or 
brick top – is member of Hypholoma genus belonging to the Strophariaceae family. 
Hypholoma fasciculare is the most well-known and studied member of the genus, which is 
identified for its antioxidant and antimicrobial activities
44
, producing different types of fungal 





, and sesquiterpenoids (fascicularones)
48, 49
. 
It was described by a German mycologist Jacob Christian Schaeffer in 1762 and he 
gave the species the scientific name Agaricus lateritius. In 1871 Agaricus lateritius was 
transferred from the genus Agaricus to the genus Hypholoma by German scientist Paul 
Kummer
50
. This mushroom is distributed throughout most of mainland Europe and also 
recorded in North America and in some Asian countries. The species is a saprophytic fungus, 
usually clustered on the dead stumps and logs of broadleaf trees. It occurs mainly from the 
late of July to the end of November. Its cap is 2-10 cm wide, dark brick red color, lighter at 
the margin. The gills are first white colored, later purple brown; the stipe is 5-12 cm long, 
whitish above, reddish brown below
51
. There is some controversy in terms of edibility of this 
species. The most field guides and other scientific sources regarding to this fungi state that it 
is edible
52
 in Japan, Korea and North America while this species has been recorded as 
inedible or even poisonous
53




3.2 Chemistry and pharmacology of Hypholoma lateritium 
In 1984, four fasciculol-type triterpenes such as fasciculol B-D and fasciculol F along with 
ergosterol, ergosterol peroxide and cerevisterol were reported from Naematoloma 
sublateritium (synonym name of H. lateritium) by Bernardi et al.
54
. Based on a study of 
Backens et al. naematolin, a sesquiterpenoid with caryophyllane skeleton, was isolated from 
culture of this species
55
. Aqueveque et al. reported that 3,5-dichloro-4-metoxy-benzyl alcohol 
and marasmal showed antimicrobial activity which have been isolated from mycelial cultures 
of Hypholoma sublateritium
56
. The extensive mycochemical analysis of the fruiting bodies by 
Yaoita et al. resulted in the identification of three new lanostane type triterpenoids, 
sublateriols A-C and three known ones, fasciculol A-C. Three of them namely sublateriol C, 
fasciculols B and C revealed significant cytotoxicity against human cancer cell lines
57
 
(Figure 1). Li et al. reported that Hypholoma lateritium mycelia contains phenolic acids 
namely 4-hydroxybenzoic acid, α-resorcylic acid, 4-coumaric acid, salicylic acid and gentisic 
acid showing high antioxidant  activity
58
. 
Only a limited number of pharmacological studies have been reported on Hypholoma 
lateritium. Most of them conducted with extracts of different polarities prepared from fungal 
sporocarps. In 1996, Yasukawa et al. found that the methanol extract of Hypholoma 
lateritium markedly inhibited the inflammatory activity induced by TPA in mice
59
. Choi et al. 
investigated the ethyl acetate fraction of H. lateritium, which showed significant free radical 
scavenging activity and inhibition of lipid peroxidation while n-hexane and dichloromethane 
fractions of H. lateritium inhibited cell proliferation and viability
60
. Lee at al. demonstrated 
that the extract of this species suppresses TNF-α-induced inflammatory response in human 
umbilical vein endothelial cells. The n-butanol fraction of H. lateritium inhibited TNF-α-
induced monocyte adhesion to endothelial cells; moreover it dose-dependently decreased the 
expression of inducible nitrogen oxygen synthase and cyclooxygenase-2
61
. In another paper 
Lee et al. investigated the inhibitory effect of H. lateritium extract on highly invasive and 
metastatic tumor cells. The n-hexane fraction of brick cap significantly inhibited the invasion 
and migration of MDA-MB-231 breast cancer cells in the Matrigel invasion assay and 
wound-healing analysis, respectively. The results obtained suggested that n-hexane extract of 
H. lateritium inhibits the metastatic potential of MDA-MB-231 cells by inhibiting the 
phosphorylation of JNK/p38 and reducing AP-1 and NF-κB DNA-binding activities
62
. 
According to the investigation of Ványolós et al., the aqueous-methanol fraction of H. 
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4 MATERIALS AND METHODS 
 
4.1 Mushroom material 
Fruiting bodies of H. lateritium were collected in September 2015 from the environs of 
Bakonybél, Hungary, and identified by Attila Sándor (Hungarian Mycological Society). A 
voucher specimen (collection number H018) has been deposited in the Department of 
Pharmacognosy, University of Szeged, Szeged, Hungary. The mushroom material was stored 
at -20 °C until processing. 
 
4.2 Extraction 
4.2.1 Extraction of the mushroom materials for preparative work 
The mushroom material (6.5 kg) was freeze dried (Hetosicc, Heto Lab Equipment, Denmark),  
and then the dry sample (630 g) was crushed in a blender (Retsch-GM200) and percolated 
with methanol (7 L) for 72 hours at room temperature. The obtained extract was evaporated 
at 40-45°C under reduced pressure. After concentration, the methanol extract (dry material 92 
g) was dissolved in 50% aqueous MeOH and subjected to solvent-solvent partition using n-
hexane (5×500 mL),  chloroform (5×500 mL),  and then ethyl acetate (5×500 mL). Each 
fraction was concentrated by using a Rotavapor R-210 (40 °C, 337 mbar).  
4.2.2 Preparation of extracts for pharmacological screening 
The fruiting bodies of H. lateritium were freeze-dried and ground with a grinder. The 
lyophilized sample (10 g) was extracted with 3×100 mL methanol by ultrasonication for 3×15 
min at room temperature. After filtration, the solutions were combined and evaporated under 
reduced pressure. The residue was dissolved in 50 mL of 50% aqueous MeOH and was 
subjected to solvent–solvent partition between n-hexane (4×25 mL) (extract A) and CHCl3 
(4×25 mL) (extract B) and the residue provided extract C. After extraction with MeOH, the 
residual mushroom material was dried and extracted with 50 mL of boiling water for 15 min. 
The filtered extract was lyophilized, giving extract D. 
 
4.3 Purification and isolation of the compounds 
4.3.1 Flash column chromatography (FCC) 
8 
 
Flash column chromatography was carried out on a CombiFlash®Rf+Lumen instrument with 
integrated UV, UV-VIS (detection at 254, 366 nm and all wavelengths) and using 12 g (FCC-
4, FCC-5, FCC-7, FCC-8), 24 g (FCC-2, FCC-3, FCC-9, FCC-11) and 80 g (FCC-1, FCC-6, 
FCC-10) RediSep Rf Gold Normal Phase Silica Flash columns and 4.3 g (RP-FCC-1, RP-
FCC-2, RP-FCC-3, RP-FCC-4) Reversed phase C18 columns (Teledyne Isco, Lincoln, USA) 
at a flow rate 18 mL/min, 30 mL/min, 35 mL and 60 mL/min, respectively. Mobile phases 
and separation times:  
FCC-1: increasing polarity of n-hexane-acetone (0% to 100% acetone), t = 60 min 
FCC-2: increasing polarity of n-hexane-acetone (0% to 30% acetone), t = 45 min 
FCC-3: increasing polarity of n-hexane-acetone (0% to 40% acetone), t = 50 min 
FCC-4: increasing polarity of n-hexane-acetone (0% to 40% acetone), t = 50 min 
FCC-5: increasing polarity of n-hexane-acetone (10% to 50% acetone), t = 55 min 
FCC-6: increasing polarity of n-hexane-acetone (0% to 100% acetone), t = 60 min 
FCC-7: increasing polarity of n-hexane-acetone (0% to 40% acetone), t = 50 min 
FCC-8: increasing polarity of n-hexane-acetone (0% to 40% acetone), t = 45 min 
FCC-9: increasing polarity of n-hexane-acetone (0% to 40% acetone), t = 50 min 
FCC-10: increasing polarity of chloroform-methanol (0% to 100% methanol), t = 60 min 
FCC-11: increasing polarity of chloroform-methanol (0% to 30% methanol), t = 45 min 
RPFCC-1: increasing polarity of water-acetonitrile (30% to 60% acetonitrile), t = 50 min 
RPFCC-2: increasing polarity of water-acetonitrile (30% to 60% acetonitrile), t = 50 min 
RPFCC-3: increasing polarity of water-acetonitrile (35% to 60% acetonitrile), t = 50 min 
RPFCC-4: increasing polarity of water-acetonitrile (30% to 70% acetonitrile), t = 50 min 
4.3.2 Thin layer chromatography 
Thin layer chromatography (TLC) was used for monitoring the flash chromatographic 
separations. TLC examination was carried out on silica gel (20x20 cm Silica gel 60 F254, 
Merck 105554).  
 
4.4 Structure determination of the isolated compounds 
Optical rotation was measured on a Perkin-Elmer 341 polarimeter. 
1
H-NMR (500 MHz), 
13
C-
NMR (125 MHz) and 2D NMR spectra were recorded in all cases, using the pulse sequences 
available in the VNMRJ 3.2 (Agilent Technologies, Santa Clara, CA, USA) or in TopSpin 
3.5 sequence libraries (Bruker). Data analysis and interpretation were performed within 
9 
 
ACD/Labs 2017.1.3 NMR Workbook Suite. NMR data were acquired on a Varian 800, 
Bruker Avance II HD 500 (Bruker, Billerica, MA, USA) or a Bruker AVANCE II HD 400 
MHz spectrometer equipped with a 
13
C enhanced salt tolerant cryoprobe, a TCI cold probe, or 
liquid nitrogen cooled Prodigy probe. methanol-d4 was used as solvent in all cases. Chemical 






HRMS analyses were performed on a LTQ FT Ultra (Thermo Fisher Scientific, 
Bremen, Germany) system with ESI ion source using positive or negative of polarity. The 
samples were dissolved in methanol. HR-MS-MS were acquired using the CID fragmentation 
method applied to the quasimolecular ion peaks (protonated/deprotonated molecular ion 
peaks or the sodium adduct ions or the molecular ion peaks with water losses). For data 
acquisition and analysis Xcalibur software version 2.0 (Thermo Fisher Scientific) was used.  
 
4.5 Pharmacological tests 
Pharmacological studies were conducted in collaboration with the Department of 
Ophthalmology and Department of Pharmacology and Pharmacotherapy (Faculty of 
Medicine, University of Szeged, Szeged, Hungary), Department of Psychiatry (Faculty of 
Medicine, University of Szeged, Szeged, Hungary) and Department of Pharmaceutical 
Botany (Faculty of Pharmacy, Jagiellonian University, Medical College, Kraków, Poland). 
4.5.1 Bdelloid rotifer assays 
The measurement of test compounds was performed on bdelloid rotifer to gain information 
about their toxicity and biological activity. Two viability markers of Philodina acuticornis 
have been chosen for the evaluation of investigated compounds. The rotifer culturing, 
harvesting, and monitoring methods were used based on previous publication by Olah et al
64
. 
Toxicity and survival lifespan (TSL) assay: The impact of the test compounds on the lifespan 
of unfed PA rotifers was evaluated. The morphological viability markers are the active 
motility of the body, normal movement of internal organs, and red eyes. 
Mastax contraction frequency (MCF) assay: The mastax (pharynx) is the chewing organ used 
in feeding which opens and closes periodically. To evaluate and standardize the viability of 
one-housed rotifers in our experiments, MCF (mastax contraction frequency, contraction/sec) 
was used as a quantitative viability marker. 
4.5.2 GIRK channel inhibitory assay 
10 
 
Investigations of the prepared extracts and natural products were performed on HEK293 
(human embryonic kidney) cells stably expressing the GIRK1/4 (Kir3.1/3.4) K
+
 channels. 
The GIRK channel inhibitory assay was carried out by the automated planar patch clamp 
technology based on the manual patch-clamp method
65
. The cell line originated from UCL 
Business PLC. Propafenone (Sigma-Aldrich Corporation, St. Louis, USA) was used as a 
positive control. Cells were maintained in DMEM (Thermo Fisher Scientific Inc., Waltham, 
USA) medium supplemented with 10% FBS (PAN-Biotech GmbH, Aidenbach, Germany) 
and 182 μg/mL zeocin (Thermo Fisher Scientific Inc., Waltham, USA). 
The following solutions were used during patch-clamp recordings (compositions in mM): 
external solution: NaCl 140, KCl 4, glucose monohydrate 5, MgCl2 1, CaCl2 3 and HEPES 10 
(pH 7.4, NaOH); high K
+ 
external solution: NaCl 135, KCl 25, MgCl2 1, CaCl2 3 and HEPES 
10 (pH 7.4, NaOH); K
+
-free external solution: NaCl 160, MgCl2 1, CaCl2 3 and HEPES 10 
(pH 7.4, NaOH); internal solution: K-gluconate 40, NaCl 20, KF 60, EGTA 20 and HEPES 
10 (pH 7.2, KOH), supplemented with 0.9 mM GTPγS before the experiments to induce 
channel activation. 
The voltage protocol for GIRK ion channel assay started with a depolarizing voltage step to 
60 mV for 100 ms before a 500 ms long hyperpolarizing ramp to −140 mV was applied. Then 
the membrane potential remained at −140 mV for 100 ms before returning to the holding 
potential of −40 mV. The inward currents were calculated from the −140 mV segment. The 
pulse frequency was approximately 0.1 Hz. At the beginning of recordings, the normal 
external solution (4 mM K
+
) was replaced to high K
+
 (25 mM K
+
) external solution in order 
to increase the current amplitude. After 2–3 min of control period, the test compounds were 
added to the cells in increasing concentrations, each for approximately 3 min. For further 
details of GIRK assay please see ref
66
. 
4.5.3 hERG channel inhibitory assay 
hERG measurements were carried out on HEK-293 cells stably transfected with cDNA 
encoding the hERG (Kv11.1) K
+ 
channel using planar patch-clamp technology adjusted by 
Polonchuk
67
. The cell line was purchased from the Cell Culture Service (Hamburg, 
Germany). 10 μM amitriptyline was used as a reference inhibitor. Cells were maintained in 
IMDM (PAN-Biotech GmbH, Aidenbach, Germany) medium supplemented with 10% FBS 
(PAN-Biotech GmbH, Aidenbach, Germany), 2 mM L-glutamine (PAN-Biotech GmbH, 
Aidenbach, Germany), 1 mM Na-pyruvate (PAN-Biotech GmbH, Aidenbach, Germany) and 
500 μg/mL G418 (Thermo Fisher Scientific Inc., Waltham, USA). 
11 
 
The following solutions were used during patch-clamp experiments (compositions in mM): 
external solution: NaCl 140, KCl 4, glucose monohydrate 5, MgCl2 1, CaCl2 3 and HEPES 
10 (pH 7.4, NaOH); internal solution: KCl 50, NaCl 10, KF 60, EGTA 20 and HEPES 10 (pH 
7.2, KOH). 
The voltage protocol for hERG ion channel started with a short (100 ms) –40 mV step to 
establish the baseline region. A depolarizing step was applied to the test potential of 20 mV 
for 3 s, and then the cell was repolarized to −40 mV (1 s) to evoke outward tail current. 
Holding potential was −80 mV. The pulse frequency was approximately 0.1 Hz. The peak tail 
current was corrected the leak current defined during the first period to −40 mV. 
Recording started in external solution. After this control period, the test compound was 




4.5.4 Anti-inflammatory assay 
4.5.4.1 Cell cultures 
Murine macrophages RAW 264.7 (TIB-71, ATCC, Manassas, VA, USA) were cultured in 
Dulbecco's Modified Eagle's Medium supplemented with 10% FBS and 1% antibiotic 
solution (100 IU/mL penicillin, 0.1 µg/mL streptomycin). Cells were maintained at 37 °C in a 
humidified atmosphere of 5% CO2 in the air and were finally seeded into a 6-well plate 
(Sarstedt AG&Co., Nümbrecht, Germany) at a density of 5 × 10
5
 cells/well in 2 mL of 
medium. At every step of the procedure, cell morphology was investigated by an inverted 
light microscope (Olympus, Tokyo, Japan). Cell viability during culturing was assessed with 
a Trypan Blue (Thermo Fisher Scientific, Waltham, MA, USA) exclusion test. RAW 264.7 
cells were activated with LPS (10 ng/mL; Sigma-Aldrich, Saint Louis, MO, USA) and 
incubated overnight. After that macrophages were treated with mushroom extracts of 
Hypholoma lateritium at concentrations of 50 and 100 µg/µL for 24 h or with the isolated 
compounds (1 and 10 µL) for 24 h. After incubation, media and the cells after scrapping were 
collected.  
4.5.4.2 Cell proliferation XTT assay 
Cell proliferation was evaluated using a sodium 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-
[(phenylamino)-carbonyl]-2H-tetrazolium) inner salt (XTT) with N-methyl-dibenzopyrazine 
methyl sulfate) functioning as the intermediate electron carrier (PMS). RAW 264.7 cells were 
seeded in 96-well plates (2.5 × 10
3
 cells/well) and incubated for 24 h. The medium was then 
12 
 
removed and 0.5; 1; 2.5; 5; 10; 50 and 100 µg/µL of mushroom extracts as well as isolated 
compounds were added to FCS-free medium and incubated for the next 24 h. Then XTT 
solution (50 μL) was added to each well and incubated for 4 h at 37 °C according to the 
manufacturer instruction (Sigma-Aldrich). The absorbance was measured at 475 nm and 630 
nm in Omega plate reader (BMG LABTECH, San Diego, CA, USA). The specific 
absorbance of the sample was expressed as follows: Specific Absorbance = A475nm (sample)-
A475nm (blank)-A660nm (sample). Cell viability was expressed as the percentage of control. 
4.5.4.3 Western blot for quantity of COX-2, cPGES and Nrf2 receptor  
M-PER mammalian protein extraction reagent (Thermo Scientific, Rockford, IL, USA) with 
protease inhibitor cocktail set III (Merck, Darmstadt, Germany) was used for cell lysates 
preparation. Total protein concentrations were determined using the Bradford reaction. 40 µg 
of proteins per sample were solubilized in a Laemmli buffer with 2% mercaptoethanol 
(BioRad, Hercules, CA, USA) and subjected to 10% SDS-polyacrylamide gel 
electrophoresis. Primary antibodies were used: anti-cyclooxygenase-2 (COX-2), anti-β-actin 
diluted 1:1000 (Thermo Fisher Scientific), anti-prostaglandin E2 synthase (Cayman 
Chemical, Ann Arbor, MI, USA) diluted 1:1000, anti-Nrf2 receptor (GeneTex, Irvine, CA, 
USA) diluted 1:200 and secondary antibody anti rabbit IgG (HRP) (Thermo Fisher Scientific, 
1:2000). Proteins were detected using the Western blotting detection kit Clarity Western ECL 
Luminol Substrate (Bio-Rad, USA). The integrated optical densities of the bands were 
quantified using Chemi Doc Camera with Image Lab software (BioRad). All the results are 
expressed as means ± standard deviation (SD). The statistical analysis was performed using 






5.1 Isolation of the compounds of Hypholoma lateritium 
The freeze-dried and ground mushroom material (630 g) was extracted with methanol (7 L). 
After concentration under vacuum, the extract was subjected to liquid-liquid partitioning to 
yield n-hexane, chloroform and ethyl acetate soluble phases (see section 4.2.1.) (Figure 2).  
The concentrated n-hexane phase (25 g) was fractionated in first step by flash column 
chromatography (FCC-1) on silica gel using an increasing polarity of the mixture n-hexane-
acetone. The fractions collected were combined based on TLC monitoring to obtain seven 
major fractions (H I-VII). Four of the united fractions were further fractionated by flash 
column chromatography (see section 4.3.1.). The first combined fraction H I+II (2.4 g) was 
purified using increasing polarity of n-hexane-acetone mixtures (FCC-2) and led to the 
isolation of compound 3 (0.92 g) and compound 4 (0.63 g). The combined fraction H III was 
fractionated in first step by flash column chromatography (FCC-3) applying an n-hexane-
acetone solvent system, then was further purified on reversed phase (RPFCC-1) using water-
acetonitrile solvent system affording compound 6 (12.4 mg). Investigation of the next 
fraction H IV (0.49 g) eluted with n-hexane-acetone 40:60 (FCC-4) yielded compound 5 (3.6 
mg). Finally the combined fraction H VII (0.83 g) was purified by flash chromatography 
(FCC-5) with n-hexane-acetone solvent system resulting in compound 7 (3.1 mg).  
The chloroform-soluble phase was evaporated, and the residue (18 g) was roughly 
separated by flash column chromatography (FCC-6) on a silica gel column using a gradient 
system of n-hexane-acetone. The obtained fractions were combined based on TLC checking, 
resulting in eleven fractions (C I-XI). The first united fraction C II (0.34 g) was separated by 
flash chromatography (FCC-7) with increasing polarity of n-hexane-acetone mixtures. The 
resulted subfraction C IIa was further purified by reversed phase flash-chromatography 
(RPFCC-2) to obtain compound 1 (3.3 mg) and compound 2 (3.3 mg). The fraction C 
VII+VIII (1.05 g) was separated by flash chromatography (FCC-8) using a mobile phase of 
n-hexane-acetone and further purified by reversed phase flash chromatography (RPFCC-3) 
using a gradient system of water-acetonitrile as mobile phase to result in compound 8 (0.32 g) 
and compound 9 (0.10 g). The fraction C IX-XI (3.89 g) was purified by flash 
chromatography (FCC-9). The subtraction C IX-XIa obtained here was further subjected to 
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reversed phase flash chromatography (RPFCC-4) and yielded compound 10 (0.42 g) and 
compound 11 (0.31 g).  
Evaporation of the ethyl acetate phase resulted in a dark brown residue (12 g), which 
was fractionated by flash chromatography (FCC-10) on a silica gel column using a gradient 
system of chloroform-methanol. The fractions with similar compositions were combined into 
six subfractions (E I-VI) according to TLC monitoring. The combined subfraction E V-VI 
was subjected to repeated flash column chromatography (FCC-11), which resulted in 
compound 12 (28 mg).  
 
 
Figure 2. Isolation of compounds from Hypholoma lateritium 
5.2 Characterization and structure determination of the isolated compounds 
The structure elucidation of the isolated compounds was performed by means of NMR and 
MS measurements. Information from 1D (
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information for the structure determination. HRMS measurements revealed the molecular 
masses and molecular compositions of the compounds. 
The investigation of the methanol extract obtained from the freeze-dried fruiting 
bodies of Hypholoma lateritium led to the isolation of 12 compounds, 8 of them for the first 
time from this species (Figure 3).  
In the n-hexane fraction of wood-decay fungus 5 secondary metabolites (3-7) were 
detected. One of them (compound 5) is a highly degraded sterol, namely demethylincisterol 
A2. The other constituents proved to be ergostane triterpenes: ergosterol [compound 3], 3β-
hydroxy-ergosta-7,22-diene [compound 4], cerevisterol [compound 6], and 3β-O-
glucopyranosyl-5,8-epidioxy-ergosta-6,22-diene [compound 7].  
From the chloroform phase of methanol extract of H. lateritium 6 compounds were 
identified. Among the compounds there are two new natural products: lanosta-7,9(11)-diene-
12β,21α-epoxy-2α,3β,24β,25-tetraol [compound 1] which belongs to lanostane type 
derivatives, and 8-hydroxy-13-oxo-9E,11E-octadecadienoic acid [compound 2], while 
compounds 8-11 are fasciculol type triterpenes. Fasciculol E (9) was first identified in the 
sporocarps of Hypholoma fasciculare
68
 , while fasciculol F (8), fasciculol C (10), and 
fasciculic acid B (11) had already been isolated from this species
54
. 
In the ethyl acetate extract of the species, uridine [compound 12] was detected. 
Ergosterol (3), 3β-hydroxyergosta-7,22-diene (4), cerevisterol (6), and 3β-O-glucopyranosyl-
5,8-epidioxyergosta-6,22-diene (7) were identified by comparing their chromatographic and 
spectroscopic data with those of authentic samples. Compounds 5 and 8–12 were structurally 
characterized based on NMR and MS spectroscopic data and confirmed by comparing them 







Figure 3. Structures of compounds from Hypholoma lateritium 
Structure elucidation of the novel natural products from Hypholoma lateritium 
Based on the HRESIMS and 
13
C-NMR data, its molecular formula was determined to be 




C, COSY, HSQC, and HMBC NMR spectra 
suggested the presence of seven tertiary methyl group, two olefinic, four oxygenated, and 
three aliphatic methines, an oxygenated and six aliphatic methylenes, together with five 
quaternary carbons. The determined data were quite similar to those reported for sublateriol 
C
72




C resonances assigned to ring D, and C-12, C-18, C-20, C-21, 
and C-28 (Table 1). The observed HMBC correlations between H-12 and C-21 and between 
H-21 and C-12 (Figure 4) suggested that instead of two hydroxyl groups present in 
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sublateriol C, an epoxy group between C12 and C21 is present in 1. This ring closure is in 
accordance with the H2O difference obtained between the elementary compositions of 
sublateriol C and 1, and explains the chemical shift differences obtained for the protons and 
carbons close to C-12 and C-20 centers. 
Based on the key NOE correlations (Figure 5) observed between H-2/H-19, H-3/H-
5/H-30, H-12/H-28/H-17, and H-18/H-20, the above presented stereochemistry is suggested. 
The configuration of C-24 center, however, could not be assigned on this basis, and the OH 
group is only tentatively given as beta-positioned. This suggestion is firstly based on the 
assumption that the ring closure does not drastically change the conformation of the side 
chain. In this case, the observed doublet nature of H-24 with coupling constants of 9.8 and 
1.6 Hz, which are closely similar to those reported for sublateriol A
72
 or other isolated 
fasciculic acid and fasciculol derivatives, having the same side chain
46, 68
, suggest a similar 
configuration of the C-24 center. Secondly, making the assumption that similar metabolic 
pathways lead to sublateriol C and 1 in the same mushroom species, a similar β orientation of 








Figure 5. Key NOE correlations determined from the ROESY spectrum of compound 1. 
 
The molecular formula of compound 2 was established as C18H29O4 from HR-ESIMS 
measurement giving a pseudomolecular ion peak at m/z 309.20673 ([M-H]
-
) in the negative 
ion mode. In accordance with this elementary composition, the 
13
C-NMR spectrum presented 
eighteen carbon resonances. Based on the 
1
H and edited HSQC spectra one methyl, ten 
methylenes, five methines, and two quaternary carbons were present in the isolated 
compound. The 
13
C chemical shifts of the quaternary carbons (182.9 and 204.0 ppm) 
suggested the presence of a carboxylic acid and a ketone functionality in 2. The multiplicities 
and coupling constants of the 
1
H resonances belonging to the methine protons suggested the 
presence of two conjugated double bonds, both in E configuration, connected to a 
hydroxylated methine and to a keto group. Putting this information together led to the 
conclusion that the isolated compound is a hydroxyl-oxo-octadecadienoic acid derivative. 
The positions of the functional groups in the fatty acid chain were unambiguously evidenced 




H COSY and HMBC correlations presented in Figure 6. Thus, the 
HMBC correlations observed between H-14 and C-16, C-12, C-13, and C-15, and between 
H-18 and C-16 and C-17, suggested that the keto group is at position 13, while the OH is 
connected to C-8. The HMBC correlation of H-11 and H-12 to C-14, and those of H-9 and H-
10 to C-8 confirmed these suggestions. Based on these data, the 8-hydroxy-13-oxo-9E,11E-
octadecadienoic acid structure is suggested for 2. The absolute stereochemistry of C-8 center 











C-NMR assignments of compound 1 (  ppm, J = Hz). 
Atom  C Shift  H Shift  H Multiplicity 
1 44.6 1.27 m 
  2.14 dd (12.7, 4.4) 
2 68.0 3.58 m 
3 82.4 2.82 d (9.7) 
4 38.9   
 5 48.8 1.11 m 
6 23.0 2.05 m 
7 123.8 5.57 d (5.2) 
8 142.2   
 9 149.2   
 10 38.8   
 11 117.2 5.30 br s 
12 79.7 3.70 br s 
13 45.3   
 14 47.8   
 15 33.0 1.74 m 
  1.46 m 
16 25.6 1.88 m 
  1.49 m 
17 46.2 1.44 m 
18 13.9 0.50 s 
19 22.3 0.97 s 
20 38.2 1.75 m 
21 73.8 3.91 dd (11.5, 4.3) 
  2.95 t (11.1) 
22 29.3 1.17 m 
  1.30 m 
23 28.6 1.54 m 
  1.15 m 
24 78.4 3.09 dd (9.8, 1.6) 
25 72.3   
 26 23.4 1.02 s 
27 24.4 1.05 s 
28 24.1 0.80 s 
29 16.1 0.80 s 







Figure 6. Key HMBC (solid line) and COSY (dotted line) correlations in compound 2. 
 




C-NMR assignments of compound 2 (  ppm, J = Hz). 
Atom  C Shift  H Shift  H Multiplicity 
1 182.9   
 2 39.1 2.16 t (7.6) 
3 27.7 1.61 m 
4 30.9 1.34 m 
5 30.6 1.34 m 
6 26.6 1.35 m 
7 38.2 1.53 m 
8 72.7 4.18 q (6.3) 
9 148.7 6.24 dd (15.2, 5.8) 
10 128.9 6.42 dd (15.2, 10.8) 
11 144.6 7.27 dd (15.6, 10.8) 
12 130.5 6.18 d (15.6) 
13 204.0   
 14 41.2 2.61 t (7.4) 
15 25.4 1.60 m 
16 32.7 1.31 m 
17 23.7 1.34 m 
 
5.3 Pharmacological investigation of the isolated compounds 
5.3.1 Activity of compounds from Hypholoma lateritium in bdelloid viability assays 
Compounds 1 and 3–11 were examined in Philodina acuticornis (PA) viability assays. 
Administration of cerevisterol (6) and 3β-O-glucopyranosyl-5,8-epidioxyergosta-6,22-diene 
(7) resulted in considerable decrease in the number of survivors in the TSL assay. The mastax 
contraction frequency (MCF) was significantly reduced by 3β-hydroxyergosta-7,22-diene (4), 
demethylincisterol A2 (5), cerevisterol (6), fasciculol E (9), and fasciculol F (8). Cerevisterol 
(6) and 3β-O-glucopyranosyl-5,8-epidioxyergosta-6,22-diene (7) were significantly toxic, 
however the latter in the presence of nutrients proved to be less toxic, and the MCF values 
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significantly increased in the survivors. The complete opposite was observed with fasciculol 
C (10), which demonstrated toxic effect with feeding, but increased the MCF values without 
nutrients. Fasciculol E (9) produced an overall significant decrease in the viability values, 
with strong dependence on the presence or lack of nutrients. Among the examined 
compounds, cerevisterol (6) proved to be the most toxic, while lanosta-7,9(11)-diene-
12β,21α-epoxy-2α,3β,24β,25-tetraol (1) had no harmful effect at all. Fasciculic acid B (11) 
exhibited unique effects, since it was used by rotifers simply as a food source (Figure 7).  
 
Figure 7. Normalized rotifer characteristics. Changes in the TSL values of the Philodina 
acuticornis after 3-day treatment (A) without feeding and (B) with feeding, compared to the 
group C. Changes in the MCF values of the Philodina acuticornis after 3-days treatment (C) 
without feeding and (D) with feeding, compared to the group C. UC: untreated control, C: 
control with 0.1% DMSO. 1, 3-11: compounds. TSL: toxicity and survival lifespan (n=12, 
well). MCF: mastax contraction frequency (n=30, individual rotifer). Values are the mean ± 
SEM; p**≤0.01, p***≤0.001, p****≤0.0001. 
5.3.2 GIRK channel inhibitory assay 
Investigation of the ion channel activity of mushroom metabolites 1, 3-11 revealed that 
lanosta-7,9(11)-diene-12β,21α-epoxy-2α,3β,24β,25-tetraol (1) exhibits notable blocking 
activity on GIRK current while it has merely weak inhibitory activity on hERG channel. 
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Initially, as part of the screening study the GIRK channel inhibitory effects of 
mushroom extracts (A-D) from Hypholoma lateritium have been examined at two 
concentrations (0.01 mg/mL and 0.1 mg/mL). Among the tested extracts CHCl3 extract 
(fraction B) revealed to be the most effective (53% decline on GIRK current) at the lower 
(0.01 mg/mL) concentration (Figure 8) (see Table 3).  
 
Figure 8. Blocking effects of fraction B of Hypholoma lateritium on GIRK current. Panel A 
shows typical current curves which were recorded during application of fraction B of 
Hypholoma lateritium at 0.01 mg/mL and 0.1 mg/mL concentrations. Inset shows the applied 
GIRK voltage protocol. The time course of calculated inward currents from the -140 mV 
segment of the current sweeps is presented on panel B. 
Table 3. GIRK channel inhibitory activity of extracts of Hypholoma lateritium at 0.01 
mg/mL and 0.1 mg/mL concentrations (n=2-3). SEM-Standard error of the mean 
Extracts  Inhibition % SEM 
  0.01 mg/mL 0.1 mg/mL 0.01 mg/mL 0.1 mg/mL 
n-Hexane (A) 33 69 3 1 
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Chloroform (B) 53 79 2 1 
Methanol (50%) (C) 25 46 2 1 
Water (D) 8 14 6 3 
 
On the basis of the results of the preliminary screening Hypholoma lateritium was selected 
for further detailed chemical examination to determine its biologically active metabolites. 
The GIRK channel modulatory properties of the isolated compounds were measured in two 
concentrations (1 μM and 10 μM) (see Table 4). 
 
Table 4. GIRK channel inhibitory activity of isolated compounds of Hypholoma lateritium at 
1 µM and 10 µM concentrations (n=2-3). SEM-Standard error of the mean 
Compound  Inhibition % SEM 
  1µM 10 µM 1 µM 10 µM 
Lanosta-7,9(11)-diene- -
epoxy- -tetraol 
(1) 27 60 5 11 
Ergosterol (3) 10 19 1 1 
-hydroxyergosta-7,22-diene (4) 8 16 1 6 
Demethylincisterol A2 (5) 11 23 3 1 
Cerevisterol (6) 7 13 1 6 
-O-Glucopyranosyl-5,8-
epidioxyergosta- 6,22-diene 
(7) 14 24 1 5 
Fasciculol F (8) 10 27 1 2 
Fasciculol E (9) 11 23 2 3 
Fasciculol C (10) 10 10 4 7 
Fasciculic acid B (11) 13 23 2 8 
The most significant inhibitory effect on GIRK channel was possessed by lanosta-7,9(11)-
diene-12β,21α-epoxy-2α,3β,24β,25-tetraol (1) while other compounds proved to exert 
moderate activity. Thus, further study has been conducted on compound 1 in order to 
determine its effect on the inward current in four concentrations on five cells.  
The GIRK currents were recorded at increasing concentrations (1 μM, 3 μM, 10 μM and 30 
μM) of compound 1 after the control period. The test compound exerted 42.0 6.4% 
inhibitory activity on GIRK channel at 1 μM. Increase of the concentration of 3 μM to 10 μM 
led to a further decrease in GIRK current (60.8 5.0% and 66.4 4.5% inhibitions, 
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respectively) whereas the current did not differ at the highest concentration of 30 μM 
(66.7 4.6% inhibition) (Figure 9).  
 
 
Figure 9. Blocking effects of compound 1 on GIRK current. Panel A depicts original current 
sweeps which were recorded during application of compound 1 at 1 μM, 3 μM, 10 μM and 30 
μM concentrations. Inset shows the applied GIRK voltage protocol. Time course of 
calculated inward currents from the −140 mV segment of the current curves is presented on 
panel B. 
 
In the detailed investigations, the dose−response curves of compound 1 were determined 
where the effect of the compound was tested in four concentrations (0.1 μM, 0.3 μM, 1 μM 
and 3 μM). The GIRK current was remarkable blocked by compound 1 in a concentration 
dependent manner. The relative IC50 value of compound 1 (the concentration corresponding 
to a response midway between the estimates of the lower and upper plateaus of the dose-







Figure 10. Inhibitory effects of compound 1 on GIRK current. Panel A displays 
representative current curves which were recorded during application of compound 1 at 0.1 
μM, 0.3 μM, 1 μM and 3 μM concentrations. Inset shows the applied GIRK voltage protocol. 
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Time course of calculated inward currents from the −140 mV segment of the current curves is 
presented on panel B. Panel C shows the dose-response curves of compound 1. The GIRK 
channel inhibitory activity of compound 1 could be characterized by the relative IC50 value of 
395.1 ± 31.8 nM (n=5). 
 
Lanosta-7,9(11)-diene-12β,21α-epoxy-2α,3β,24β,25-tetraol (1) was also tested on HEK-
hERG cell line and selectivity of its GIRK blocking effect was evaluated with these 
experiments. Compound 1 possessed low inhibitory activity (7.9   2.8%) on the hERG 
channel at 100 μM concentration, while it exhibited a potent GIRK inhibitory, presenting 
more than three orders of magnitude higher blocking activity on GIRK channel compared to 
the results obtained on hERG channel. Original hERG current sweeps during the application 
of compound 1 at 100 μM concentration and the time course of decrease in the peak tail 







Figure 11. Effects of compound 1 on hERG current. Panel A presents typical hERG current 
sweeps during the application of 100 μM compound 1. The inset shows the applied hERG 
voltage protocol. The original current traces reveal that 1 slightly blocked the hERG channel, 
while the addition of reference compound amitriptyline (10 μM) fully blocked the current. 
The time course of decrease in the peak tail current is presented on panel B. 
 
5.3.3 Anti-inflammatory assay 
Examination of the anti-inflammatory properties of Hypholoma lateritium extracts, in RAW 
264.7 cells activated with LPS and incubated with chloroform, methanol and water extracts 
of Hypholoma lateritium revealed an increase of Nrf2 (nuclear factor (erythroid-derived 2)-
like 2). In the same way, higher levels of cPGES protein were observed in macrophages co-
treated with LPS and in all extracts, but the values obtained were significantly lower 
compared to those of the LPS-activated cells. The investigations highlighted a decrease in 
COX-2-levels in RAW 264.7 cells co-treated with mushroom extracts and LPS in comparison 









Figure 12. Levels of COX-2 (a), cPGES (b) and Nrf2 (c) and their representative blots (d) in 
RAW 264.7 cells incubated with extracts of Hypholoma lateritium and activated with LPS. # 
vs control, * vs LPS, p<0.05. A: n-Hexane extract, B: Chloroform extract, C: 50% MeOH 




To identify the secondary metabolites of Hypholoma lateritium responsible for the observed 
anti-inflammatory properties the pharmacological assays for the characteristic compounds of 
H. lateritium have been performed.  
The experiments revealed that compounds 1, 5, 8-11 activated cPGES, but levels of this 
protein were lower than those in LPS-activated RAW 264.7 cells. In cells activated with LPS 
and incubated with compounds 1, 5, 8-11 we experienced an increase of Nrf2. Compounds 1, 
5, 8-11 in general proved to possess similar activities; however fasciculol C (10) represents a 
particular case, because when cells were treated with 10 alone the amount of cPGES was the 
lowest, while the level of Nrf2 was the highest among the values obtained in all experiments. 
Macrophages activated with LPS and incubated with fungal metabolites were characterized 








Figure 13. Levels of COX-2 (a), cPGES (b) and Nrf2 (c) and their representative blots (d) in 
RAW 264.7 cells incubated with compounds isolated from Hypholoma lateritium and 
activated with LPS. # vs control, * vs LPS, p<0.05. 1-Fasciculic acid B (11), 2-Fasciculol E 
(9), 3-Fasciculol C (10), 4-Lanosta-7,9(11)-diene-12β,21α-epoxy-2α,3β,24β,25-tetraol (1), 5-






6.1 Screening studies 
Fungal species were collected from the environs of Bakonybél, Hungary. The mushroom 
samples were extracted with an amphipolar solvent (methanol), which permitted the isolation 
of lipophilic and polar components as well. Solvent-solvent partitioning between the aqueous 
methanol extract and n-hexane, then CHCl3, as well as the extraction with H2O afforded 
fractions with different polarities. 
In the study effects of fungal extracts on the G-protein-activated inwardly rectifying 
potassium channel were screened using the automated patch-clamp method. The organic (n-
hexane, chloroform, and 50% methanol) and aqueous extracts of Hypholoma lateritium were 
tested in this assay, and among the extracts, CHCl3 extract revealed to be the most effective 
(53% decline on GIRK current). 
Organic (n-hexane, CHCl3 and 50% methanol) and water extracts of H. lateritium 
were subjected to in vitro assays to determine pro-inflammatory protein levels, such as 
cyclooxygenase-2 (COX-2), cytosolic prostaglandin E2 synthase (cPGES), and antioxidant 
nuclear factor (erythroid-derived 2)-like 2 (Nrf2). Fungal extracts demonstrated significant 
activities on pro-inflammatory protein levels with minor differences among the activities of 
the fractions of different polarities.  
In conclusion, the ion channel activity and anti-inflammatory screening studies 
demonstrated that the examined mushroom H. lateritium and its secondary metabolites could 
have several beneficial pharmacological properties providing multiple opportunities for the 
potential therapeutic application of AF and inflammation.  
 
6.2 Investigation of Hypholoma lateritium 
Mycochemical investigation of fruiting bodies of H. lateritium resulted in the isolation of 12 
compounds, including 2 new natural products. The structures were elucidated on the basis of 
spectroscopic methods, including 1D and 2D NMR and MS analyses. Biological 





6.2.1 Isolation of bioactive compounds 
Our prior investigations of the extracts with different polarity prepared from the aerial parts 
of Hypholoma lateritium and literature review resulted in the conclusion that the lipophilic, 
especially chloroform and n-hexane extracts, contain the bioactive secondary metabolites.  
In the initial step of the mycochemical work, the dried mushroom materials were 
percolated with an amphipolar solvent (MeOH) at room temperature; then solvent–solvent 
extraction was used, which led to the n-hexane, chloroform and ethyl acetate fractions.  The 
fractions obtained were subjected to normal and reversed phase flash chromatography 
procedures in order to separate the compounds responsible for the pharmacological activities.  
The n-hexane phase was fractionated by FCC and the combined fractions were 
further analyzed using repeated FCC and RP-FCC. Multiple chromatographic separations 
led to the isolation of five compounds (3-7). The purification of the chloroform extract of the 
species was first carried out by FCC followed by RP-FCC affording six compounds (1, 2, 8-
11). Two of them (1, 2) were new natural products while four (8-11) were previously known 
fasciculol-type triterpenes. The ethyl acetate fraction of H. laterirum was separated by 
repeated FCC steps to give compound 12.  
 
6.2.2 Structure elucidation 
The structures of the isolated compounds (1-12) were elucidated by means of spectroscopic 
methods. The molecular masses and compositions were obtained from MS investigations. 
The most useful data concerning the structures were furnished by 1D and 2D NMR 








H COSY, HSQC and HMBC experiments, the 
constitutions of the compounds were described and then the relative configurations were 





C assignments were made for the characterization of the new 
compounds and also in the case of some known compounds, where previously published data 
were incomplete.  
 
Triterpenes from Hypholoma lateritium 
The structure determination of compounds isolated from n-hexane phases of H. lateritium led 
to the identification of 5 triterpenes.  
Ergosterol (3) and 3β-hydroxyergosta-7,22-diene (4) are common steroids with a 
widespread distribution in fungal species. Ergosterol is the primary sterol in the cell 
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membranes of fungi and utilized for fungal growth
73
. It was first isolated from Claviceps 
purpurea over 130 years ago
74
. Cerevisterol isolated from the unsaponifiable fraction of the 
fat of the common yeast,  Saccharomyces cerevisiae
75
, its chemical structure and some of its 
properties were described by Honeywell and Bills
76
.  
According to the spectroscopic measurements compound 7 demonstrated to be 3β-O-
glucopyranosyl-5,8-epidioxyergosta-6,22-diene possessing a peroxide linkage between C5 
and C8. This secondary metabolite was previously detected in the edible mushroom Hericium 
erinaceus
77
. Demethylincisterol A2 (5) identified first from a marine sponge Homaxinella sp., 
is a highly degraded sterol belonging to the class of incisterols
71
.  
From the chloroform phase of the methanolic extract of Hypholoma lateritium 6 
compounds were identified. Fasciculic acid B (11) was first isolated from the toxic 
mushroom Naematoloma fasciculare, having potent calmodulin antagonist activity
47
. 
Fasciculol C (10) and its depsipeptides fasciculol E (9) and F (8) were detected from the ethyl 
acetate extracts of the fruit bodies of Naematoloma fasciculare in 1977 by Ikeda et al.
78
. Four 




6.2.3 Biological activities of the isolated compounds from Hypholoma lateritium 
6.2.3.1 Toxicity and viability of compounds on bdelloid rotifers 
Based on our screening results, the compounds 1, 3-11 detected in Hypholoma lateritium, 
were evaluated for their toxicity and viability in vivo using the bdelloid rotifer assay. Most of 
the tested compounds demonstrated low toxicity, even though cerevisterol (6) and 3β-O-
glucopyranosyl-5,8-epidioxyergosta-6,22-diene (7) caused significant decrease in the number 
of animals. According to the mastax contraction frequency values, compound 7 exhibited the 
highest viability compared to the others. Here we report for the first time preliminary in vivo 
toxicity results for compounds 1, and 3-11.  
Most of the examined compounds have been poorly investigated regarding their 
toxicity. The median lethal dose (LD50) in mice was available only for fasciculol F (8) and E 
(9). Fasciculol F and E gave LD50 values of 168 mg/kg and 50 mg/kg, respectively, in 
intraperitoneal administration in mice
79
. Demethylincisterol A2 (5) isolated from the 
Homaxinella sp. showed a significant cytotoxicity against a panel of five human tumor cell 
lines. The extensive mycochemical analysis of the aerial parts of Naematoloma sublateritium 
by Yaoitaa et al. resulted in the identification of three new lanostane type triterpenoids, 
sublateriols A-C and three known ones, fasciculol A-C. Three of them namely sublateriol C, 
34 
 
fasciculol B and C revealed significant cytotoxicity against human cancer cell lines. 
Ergosterol (3) isolated from the fruiting bodies of the fungus Ganoderma lucidum, was 
examined for their inhibitory effects on the induction of Epstein-Barr virus early antigen 
(EBV-EA) by 12-O-tetradecanoylphorbol 13-acetate (TPA) in Raji cells, a known primary 
screening test for anti-tumor promoters. Ergosterol showed low inhibitory effects on EBV-
EA induction, with IC50 values of 516 mol ratio/32 pmol TPA
80
. 3β-O-Glucopyranosyl-5,8-
epidioxyergosta-6,22-diene (7) identified in the methanol extract of Scleroderma bovista Fr. 
showed significant antiproliferative activity on A2780 human cancer cell line (53.27 ± 
6.37%)
81
. Cerevisterol (6) identified in the n-hexane extract of T. populinum, proved to be the 
most active against T47D human breast cancer cell line (50.2 ± 1.6%)
82
.  
6.2.3.2 Effects of compounds on GIRK and hERG channels 
In the frame of the GIRK channel inhibitory investigation 4 extracts from Hypholoma 
lateritium were tested, among them CHCl3 extract proved to be the most active (53% decline 
on GIRK current) at 0.01 mg/mL concentration. Ten mushroom metabolites (1, 3-11) were 
investigated in order to determine their GIRK blocking potency. Lanosta-7,9(11)-diene-
12β,21α-epoxy-2α,3β,24β,25-tetraol (1) demonstrated remarkable blocking activity on GIRK 
current (IC50 395.1±31.8 nM). Evaluation of the selectivity of the GIRK inhibitory effect 
exhibited that lanosta-7,9(11)-diene-12β,21α-epoxy-2α,3β,24β,25-tetraol (1) has only weak 
inhibitory activity on hERG channel (7.9±2.8% at 100 μM). 
A literature review of the previous investigations suggest that cardiac action of diterpenes
83-85
 
were mostly studied. However, merely a few of the articles dealing with the cardiac effect of 
triterpenes are available
86-88
. To the best of our knowledge our research team reported for the 
first time that a lanostane-type triterpene from H. lateritium was able to substantially prevent 
potassium current through GIRK channels. 
6.2.3.3 Anti-inflammatory activity of compounds from Hypholoma lateritium 
According to the preliminary studies organic and water extracts of H. lateritium exerted 
significant inhibitory activity on COX-2 and were capable to stimulate the Nrf2 pathway. Our 
detailed experiments (Figure 12) showed that compounds 1, 5, 8-11 activated cPGES, but 
levels of this protein were lower than those in LPS-activated RAW 264.7 cells. In cells 
activated by LPS and incubated with compounds 1, 5, 8-11 were characterized by increased 
Nrf2 level. Compounds 1, 5, 8-11 in general demonstrated similar activities; however 
fasciculol C (10) represents a particular case, because when cells were treated with 10 alone 
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the amount of cPGES was the lowest, while the level of Nrf2 was the highest among the 
values obtained in the experiments. Macrophages activated by LPS and incubated with fungal 
metabolites expressed low level of COX-2 when compared to LPS-activated macrophages. 
Nrf2 is an essential transcription factor that regulates the expression of antioxidant proteins 
that protect against oxidative damage caused by injury and inflammation. It is a key 
participant of cellular defense mechanism; activation of Nrf2 leads to a subsequent 
production of proteins and antioxidant enzymes, providing the damaged cells and tissues with 
a complex antioxidant defense. Plenty of studies unequivocally demonstrate that many plant 
metabolites from fruits and vegetables, e.g. curcumin, resveratrol and sulforaphane are 
capable of regulating Nrf2
89-91
. Although many plants produce a variety of compounds with 
Nrf2 activity, the potential of mushroom metabolites in this view is largely unexplored. 
However, extracts from Agaricus bisporus mycelia enriched in α-linolenic acid presented 
Nrf2 modulating activity
92
. Only a few fungal compounds are known to regulate the Nrf2 
pathway, including the benzoid-type antrolone and the ubiquinone derivative antroquinonol 
identified in Antrodia sp., and several steroids from the renowned Ganoderma lucidum
93, 94
.  
Fasciculol C (10), E (9) and fasciculic acid B (11), isolated from the toxic mushroom 
H. fasciculare demonstrated potent calmodulin antagonist activity
47
. A study by Kubo et al. 
confirmed that fasciculol F (8) separated from the same species also had calmodulin-
inhibitory activity
95
. Calmodulin is an essential protein regulates a remarkable array of 
physiological events by binding with calcium in intracellular
96
. Calcium/calmodulin-
dependent protein kinase II (CaMKII) is activated in several heart disease with an 








The aim of our research work was to isolate and characterize the biologically active 
compounds from Hypholoma lateritium, and to evaluate its extracts and compounds for 
toxicity, GIRK channel inhibitory and anti-inflammatory activities. 
The isolation of the compounds was carried out by a multistep separation procedure 
using FCC and RP-FCC. The structures of the obtained compounds were elucidated by means 
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were accomplished for the characterization of the compounds. 
Two new natural products lanosta-7,9(11)-diene-12β,21α-epoxy-2α,3β,24β,25-tetraol 
(1) and 8-hydroxy-13-oxo-9E,11E-octa-decadienoic acid (2), together with 10 known ones, 
four ergostane type triterpenes, such as ergosterol (3), 3β-hydroxyergosta-7,22-diene (4), 
cerevisterol (6), and 3β-O-glucopyranosyl-5,8-epidioxyergosta-6,22-diene (7), a highly 
degraded sterol demethylinciterol A2 (5), and four fasciculol-type triterpenes, namely 
fasciculol F (8), fasciculol E (9), fasciculol C (10), and fasciculic acid B (11) were isolated 
from H. lateritium; compound 12 was identified as uridine. Six (4-7, 9, 12) of the known 
compounds were identified in this species for the first time. 
The toxicity of compounds isolated from H. lateritium were examined in vivo using 
the bdelloid rotifer assay. On the basis of our screening results, cerevisterol (6) and 3β-O-
glucopyranosyl-5,8-epidioxyergosta-6,22-diene (7) exerted high toxicity, while lanosta-
7,9(11)-diene-12β,21α-epoxy-2α,3β,24β,25-tetraol (1) showed no toxic effect.  
In our search for mushroom species for potential GIRK channel inhibitory activity, 
the chloroform extract of H. lateritium proved to be the most active (53% decline on GIRK 
current) at 0.01 mg/mL concentration. Among fungal metabolites, lanosta-7,9(11)-diene-
12β,21α-epoxy-2α,3β,24β,25-tetraol (1) demonstrated notable blocking activity on GIRK 
current. Investigation of the ion channel selectivity it was found that compound (1) has only 
weak inhibitory activity on hERG channel. 
The anti-inflammatory effects of lipophilic and hydrophilic extracts and compounds 
1, 5, and 8-11 were evaluated in vitro using RAW 264.7 cells, which revealed significant 
activities on pro-inflammatory protein levels, COX-2, cPGES and Nrf2 with minor 
differences among the activities of the fractions of different polarities. All compounds proved 




In conclusion, in-depth mycochemical and pharmacological investigations of H. 
lateritium afforded promising results, providing multiple opportunities for the potential 
therapeutic application of the isolated fungal metabolites, particularly regarding their 
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Abstract: Twelve compounds (1–12) were isolated from the methanol extract of brick cap mushroom
(Hypholoma lateritium (Schaeff.) P. Kumm.). The structures of the compounds were elucidated using
extensive spectroscopic analyses, including NMR and MS measurements. Lanosta-7,9(11)-diene-
12β,21α-epoxy-2α,3β,24β,25-tetraol (1) and 8-hydroxy-13-oxo-9E,11E-octa-decadienoic acid (2)
were identified as new natural products, together with ten known compounds, from which 3β-
hydroxyergosta-7,22-diene (4), demethylincisterol A2 (5), cerevisterol (6), 3β-O-glucopyranosyl-5,8-
epidioxyergosta-6,22-diene (7), fasciculol E (9), and uridine (12) were identified in this species for the
first time. The isolated triterpenes (1, 3–11) were investigated for their toxicity in vivo using bdelloid
rotifer assays. Most of the examined steroids in general showed low toxicity, although the effects
of the compounds varied in a wider range from the non-toxic lanosta-7,9(11)-diene-12β,21α-epoxy-
2α,3β,24β,25-tetraol (1) to the significantly toxic cerevisterol (6), with substantial dependence in some
cases on the presence of nutrient in the experimental environment.
Keywords: Hypholoma lateritium; mushroom; triterpenes; toxicity; bdelloid rotifer
1. Introduction
Over human history, mushrooms have acquired a good reputation as a popular and valuable
foodstuff, being low in calories but high in essential amino acids, vitamins, and fiber. They can be
integrated into a versatile and balanced diet, representing not only a tasty and healthy food, but also
a rich source of biologically active natural products with therapeutic potential. According to the report
of the Food and Agriculture Organization (FAO), there are records of more than 1100 mushrooms with
varying degrees of edibility from 85 countries around the world [1]. The question of edibility is fairly
subjective; the comestibility of some mushrooms can vary from one region to another, while certain
species are eaten only after they are processed in a specific way.
A particular case is represented by Hypholoma lateritium ((Schaeff.) P. Kumm. (syn. Hypholoma
sublateritium (Fr.) Quél. and Naematoloma sublateritium (Fr.) P. Karst.)), also known as brick cap,
which is a popular edible mushroom in Japan, Korea, and the United States, but in Europe it is
Molecules 2019, 24, 301; doi:10.3390/molecules24020301 www.mdpi.com/journal/molecules
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considered inedible or even poisonous [2,3]. H. lateritium is a wood-decay fungus growing in clusters
on hardwood logs and stumps, widely distributed throughout Europe, North America, and the Far East.
Compared to its more common relative, the poisonous sulfur tuft (Hypholoma fasciculare), the chemistry
and pharmacology of H. lateritium are less known. This species produces several triterpenes, e.g.,
fasciculols B and C, their depsipeptides (fasciculols D and F), and sublateriols A–C [4,5]. Naematolin,
a caryophyllane derivative with cytotoxic activity, was isolated from cultures of H. lateritium [6].
Attempts have been made to characterize the possible mechanism of action behind the antitumor
and anti-inflammatory effects of H. lateritium extracts [7,8], as well as to explore the antimicrobial,
antioxidant, and xanthine oxidase inhibitory properties of this species [9–11]. The current study was
performed to identify the major secondary metabolites of H. lateritium and characterize their toxicity in
bdelloid rotifer assays. Bdelloid rotifers, as micro-invertebrates, are widely used animal models in
toxicity-, aging-, and longevity-related research [12–14]. These organisms are multicellular animals
with well-defined anatomical characteristics, possessing a ciliated head structure, bilateral ovaries,
mastax, ganglia, muscle, digestive, nervous, and secretory systems, and photosensitive and tactile
organs [15,16]. Taking into account the above-mentioned characteristics together with their short
lifespan and specific measurable phenotypic features and viability markers [17], bdelloids are useful as
in vivo toxicological and lifespan models.
2. Results and Discussion
As part of our ongoing effort to search for biologically-active natural fungal products, our attention
has been drawn to the mushroom H. lateritium, a species known for its controversial edibility, but
investigated to a weaker extent. In this vein, our main goal was to identify the characteristic compounds
of H. lateritium and to evaluate their toxicity in vivo using bdelloid rotifer assays. The collected fruiting
bodies of H. lateritium were freeze-dried, and then were extracted with methanol on room temperature.
The crude extract was subjected to solvent-solvent partition with n-hexane, chloroform, and then ethyl
acetate. The obtained n-hexane, chloroform, and ethyl acetate phases were applied to an extensive
separation process, using a combination of flash chromatography steps on normal and reversed phases
to afford 12 compounds (Figure 1).
Compound 1 was isolated as a colorless gum. Based on the HRESIMS and 13C-NMR data, its
molecular formula was determined to be C30H48O5. Consecutive analysis of the 1H, 13C, COSY, HSQC,
and HMBC NMR spectra (see Supplementary Materials) suggested the presence of seven tertiary
methyl group, two olephinic, four oxygenated, and three aliphatic methines, an oxygenated and six
aliphatic methylenes, together with five quaternary carbons. The determined data were quite similar to
those reported for sublateriol C [5], except for the 1H and 13C resonances assigned to ring D, and C-12,
C-18, C-20, C-21, and C-28. The observed HMBC correlations between H-12 and C-21 and between
H-21 and C-12 (Figure 2) suggested that instead of two hydroxyl groups present in sublateriol C,
an epoxy group between C12 and C21 is present in 1. This ring closure is in accordance with the H2O
difference obtained between the elementary compositions of sublateriol C and 1, and explains the
chemical shift differences obtained for the protons and carbons close to C-12 and C-20 centers.
Based on the key NOE correlations (Figure 3) observed between H-2/H-19, H-3/H-5/H-30,
H-12/H-28/H-17, and H-18/H-20, the above presented stereochemistry is suggested.
The configuration of C-24 center, however, could not be assigned on this basis, and the OH group
is only tentatively given as beta-positioned. This suggestion is firstly based on the assumption that the
ring closure does not drastically change the conformation of the side chain. In this case, the observed
doublet nature of H-24 with coupling constants of 9.8 and 1.6 Hz, which are closely similar to those
reported for sublateriol A [5] or other isolated fasciculic acid and fasciculol derivatives, having the
same side chain [18,19], suggest a similar configuration of the C-24 center. Secondly, making the
assumption that similar metabolic pathways lead to sublateriol C and 1 in the same mushroom species,
a similar β orientation of 24-OH is suggested. Putting all these together, the structure of compound 1
is suggested as lanosta-7,9(11)-diene-12β,21α-epoxy-2α,3β,24β,25-tetraol.
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Compound 2 was obtained as colorless gum. Its molecular formula, C18H29O4, was established
from HR-ESI MS measurement giving a pseudomolecular ion peak at m/z 309.20673 ([M − H]−) in the
negative ion mode. In accordance with this elementary composition, the 13C-NMR spectrum presented
eighteen carbon resonances. Based on the 1H and edited HSQC spectra one methyl, ten methylenes,
five met in s, and two quaterna y carbons wer present in the isolate compound. Th 13C chemical
shifts of the quaternary carbons ( 82.9 and 204.0 ppm) suggested he presence of a carboxylic acid and
a ketone functionality. The multiplicities and coupling constants of the 1H resonances belonging to
the methine protons suggested the presence of two conjugated double bonds, both in E configuration,
connected to a hydroxylated methine and to a keto group. Putting this information together led to the
conclusion that the isolated compound is a hydroxyl-oxo-octadecadienoic acid derivative. The positions
of the functional groups in the fatty acid chain were unambiguously evidenced on the basis of the
COSY and HMBC correlations presented in Figure 4.Molecules 2019, 24 FOR PEER REVIEW  5 
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Thus, the HMBC correlations observed between H-14 and C-16, C-12, C-13, and C-15, and between
H-18 and C-16 and C-17, suggested that the keto group is at position 13, while the OH is connected to
C-8. Th HMB correlation of H-11 and H-12 to C-14, and those of H-9 and H-10 to C-8 confirmed
these suggestion . Based on these data, the 8-hy roxy-13-oxo-9E,11E-octadecadien ic acid structure
is suggested for 2. The absolute stereochemistry of C8 cente was not determined. Ergosterol (3),
3β-hydroxyergosta-7 22-diene (4), cerevisterol (6), and 3β-O-glucopyranosyl-5,8-epidioxyergost -6,22-
diene (7) were ide tified by comparing their chromatographic and spectroscopic data with those of
authentic samples. Compounds 5 and 8–12 were structurally characterized on the basis of NMR and
MS spectroscopic data (see Supplementary Materials) and confirmed by comparing the to those
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reported earlier in the literature [4,5,18–24]. Demethylincisterol A2 (5) is a highly degraded sterol
isolated first from a marine sponge of Homaxinella sp. [24]. Fasciculol E (9) was first identified in the
sporocarps of Hypholoma fasciculare [19], while fasciculol F (8), fasciculol C (10), and fasciculic acid B
(11) were previously isolated from H. lateritium [4]; compound 12 was determined as uridine.
The isolated compounds were subjected to bdelloid rotifer assay in order to gain information
about their toxicity and biological activity. Two viability markers of Philodina acuticornis have been
used to measure the effect of compounds 1 and 3–11 in terms of survival and resilience. Decreases or
increases in the toxicity and survival lifespan (TSL) and in the mastax contraction frequency (MCF) are
in correlation with the physiological state of individuals. The changes in TSL values, which provides
mortality rate, are rather straightforward results. The MCF index assays the chewing organ function,
providing information about the effect of the compounds on organs level and gives a more complex
image to the results. Compounds which caused significant decrease in the number of survivors were
cerevisterol (6) and 3β-O-glucopyranosyl-5,8-epidioxyergosta-6,22-diene (7) (see Figure 5).
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3-day treatment (A) without feeding and (B) with feeding, compared to the group C. Changes in the
MCF values of the Philodina acuticornis after 3-day treatment (C) without feeding and (D) with feeding,
compared to the group C. UC: untreated control, C: control with 0, 1% DMSO. 1, 3–11: compounds.
TSL: toxicity and survival lifespan (n = 12, well). MCF: mastax contraction frequency (n = 30, individual
rotifer). Values are the mean ± SEM; p ** ≤ 0.01, p *** ≤ 0.001 and p **** ≤ 0.0001.
Significant decrease was observed in the MCF values of 3β-hydroxyergosta-7,22-diene (4),
demethylincisterol A2 (5), cerevisterol (6), fasciculol E (9), and fasciculol F (8). Cerevisterol (6) and
3β-O-glucopyranosyl-5,8-epidioxyergosta-6,22-diene (7) were significantly toxic, however the latter
in the presence of nutrients proved to be less toxic, and the MCF values significantly increased in
the survivors. The complete opposite was observed with fasciculol C (10), which demonstrated
toxic effect with fee ing, but increased the MCF value without nutrients. Fasciculol E (9) c used an
overall significa t decr ase i the viability values, with strong dependence on the presence or lack
of nutrients. Amo g the examined compounds, ce evisterol (6) proved to be the most tox , while
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lanosta-7,9(11)-diene-12β,21α-epoxy-2α,3β,24β,25-tetraol (1) had no harmful effect at all. Fasciculic
acid B (11) exhibited unique effects, since it was used by rotifers simply as a food source. Overall, we can
state that most of the investigated steroids in general had low toxicity, although the effect of compounds
varied in a wider range from non-toxic lanosta-7,9(11)-diene-12β,21α-epoxy-2α,3β,24β,25-tetraol (1) to
significantly toxic cerevisterol (6), with strong dependence in some cases on the presence of nutrients
in the experimental environment.
3. Materials and Methods
Optical rotations were measured with a Perkin-Elmer 341 polarimeter. Flash chromatography
was carried out on a CombiFlash®Rf+Lumen Instrument (Teledyne ISCO, Lincoln, NE, USA) with
integrated UV, UV-VIS, and ELS detection using RediSep Rf Gold normal and reversed phase flash
columns (4, 12, 40 and 80 g) (Teledyne Isco, Lincoln, NE, USA). HRMS analyses were performed on
a LTQ FT Ultra (Thermo Fisher Scientific, Bremen, Germany) system. The samples were dissolved
in methanol. ESI ionization was used in all cases operating in positive or in case of compound 7
in the negative ion mode. HR-MS-MS were acquired using CID fragmentation method applied on
the quasimolecular ion peaks (protonated/deprotonated molecular ion peaks or the sodium adduct
ions or the molecular ion peaks with water losses). Data acquisition and analysis were accomplished
with Xcalibur software version 2.0 (Thermo Fisher Scientific). NMR data were acquired on a Varian
800, Bruker Avance II HD 500 (Bruker, Billerica, MA, USA) or a Bruker AVANCE II HD 400 MHz
spectrometer equipped with a 13C enhanced salt tolerant cryoprobe, a TCI cold probe, or liquid nitrogen
cooled Prodigy probe. MeOD-d4 was used as solvent in all cases. Chemical shifts are reported in the
delta scale relative to the residual solvent signals (3.31 and 49.15 ppm for 1H and 13C, respectively).
Standard one and two dimensional NMR spectra were recorded in all cases, using the pulse sequences
available in the VNMRJ 3.2 (Agilent Technologies, Santa Clara, CA, USA) or in TopSpin 3.5 sequence
libraries (Bruker). Data analysis and interpretation were performed within ACD/Labs 2017.1.3 NMR
Workbook Suite.
3.1. Mushroom Material
Fruiting bodies of Hypholoma lateritium were collected in September 2015 from the environs of
Bakonybél, Hungary, and identified by Attila Sándor (Hungarian Mycological Society). A voucher
specimen (collection number H018) has been deposited at the Department of Pharmacognosy, University
of Szeged, Szeged, Hungary.
3.2. Extraction and Isolation
The mushroom material (6.5 kg) was freeze dried and then the dry sample (630 g) was extracted with
methanol (7 L) at room temperature. After concentration, the methanol extract (92 g) was dissolved in
50% aqueous MeOH and subjected to solvent-solvent partition using n-hexane (5 × 500 mL), chloroform
(5 × 500 mL), and then ethyl acetate (5 × 500 mL). The n-hexane soluble phase (25 g) was applied to flash
chromatography (FC) on silica gel using gradient system of n-hexane–acetone (0% to 100%, t = 60 min),
affording 7 combined fractions (H 1–7). Fractions H 1–2 (2.4 g) were further separated by FC applying
an n-hexane–acetone solvent system (0% to 30%, t = 45 min), which resulted in compounds 3 (0.92 g)
and 4 (0.63 g). Fraction H 3 was first separated by FC on silica gel using n-hexane–acetone eluent
with increasing polarity (0% to 40% acetone, t = 50 min), then was further purified on reversed phase
using water–acetonitrile solvent system (30% to 60% acetonitrile, t = 50 min), and led to the isolation
of 6 (12.4 mg). Fraction H 4 (0.49 g) was subjected to normal phase FC using an n-hexane-acetone
system (0% to 40% acetone, t = 50 min) to give compound 5 (3.6 mg). The combined fraction H 7
(0.83 g) was analyzed in similar conditions (n-hexane–acetone, 10% to 50% acetone, t = 55 min),
resulting in compound 7 (3.1 mg). The chloroform soluble phase (18 g) was first separated by normal
phase FC, applying a solvent system of n-hexane–acetone (0% to 100%, t = 60 min) to obtain 11 major
combined fractions (C 1–11), while the ethyl acetate phase (12 g) was subjected to normal phase FC
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using a solvent system of chloroform–methanol, which resulted in six major fractions (E 1–6). Fraction
C 2 (0.34 g) was separated on normal phase (solvent system n-hexane–acetone, 0% to 40% acetone,
t = 50 min), followed by reversed phase flash chromatography purification (30% to 60% acetonitrile,
t = 50 min) to give compounds 1 (3.3 mg) and 2 (3.3 mg). Fractions C 7–8 (1.05 g) were further
purified on normal (n-hexane–acetone, 0% to 40% acetone, t = 45 min) and reversed phase (35% to
60% acetonitrile, t = 50 min) flash chromatography in subsequent steps to afford 8 (0.32 g) and 9
(0.10 g). The combined fractions C 9–11 (3.89 g) and E 1 (1.26 g) were separated by subsequent use of
normal (n-hexane–acetone, 0% to 40% acetone, t = 50 min) and reversed phase (30% to 70% acetonitrile,
t = 50 min) flash chromatography to obtain 10 (0.42 g) and 11 (0.31 g). Finally, compound 12 (28 mg)
was isolated from fractions E 5–6 using a chloroform–methanol solvent system (0% to 30% methanol,
t = 45 min).
Lanosta-7,9(11)-diene-12β,21α-epoxy-2α,3β,24β,25-tetraol (1): colorless gum; [α]26D +7 (MeOH, c 0.2),
1H-NMR and 13C-NMR data, see Table 1. HRESIMS: m/z 395.33056 [M + H-H2O-H2O]+
(delta = −0.3 ppm; C28H43O). HR-ESI-MS-MS (CID = 35%; rel. int. %): 377(100); 325(16); 311(51);
307(17); 293(29); 269(12); 251(5).
8-Hydroxy-13-oxo-9E,11E-octadecadienoic acid (2): colorless gum; [α]26D –5 (MeOH, c 0.2),
1H-NMR
and 13C-NMR data, see Table 2. HRESIMS: m/z 309.20673 [M − H]− (delta = −1.3 ppm; C18H29O4).
HR-ESI-MS-MS (CID = 55%; rel. int. %): 291(100); 209(8); 195(21); 171(4).
Table 1. The 1H and 13C-NMR assignments of compound 1.
Atom C Shift H Shift H Multiplicity
1 44.6 1.27 m
2.14 dd (12.7, 4.4)
2 68.0 3.58 m
3 82.4 2.82 d (9.7)
4 38.9
5 48.8 1.11 m
6 23.0 2.05 m




11 117.2 5.30 br s
12 79.7 3.70 br s
13 45.3
14 47.8
15 33.0 1.74 m
1.46 m
16 25.6 1.88 m
1.49 m
17 46.2 1.44 m
18 13.9 0.50 s
19 22.3 0.97 s
20 38.2 1.75 m
21 73.8 3.91 dd (11.5, 4.3)
2.95 t (11.1)
22 29.3 1.17 m
1.30 m
23 28.6 1.54 m
1.15 m
24 78.4 3.09 dd (9.8, 1.6)
25 72.3
26 23.4 1.02 s
27 24.4 1.05 s
28 24.1 0.80 s
29 16.1 0.80 s
30 27.8 0.91 s
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Table 2. The 1H and 13C-NMR assignments of compound 2.
Atom C Shift H Shift H Multiplicity
1 182.9
2 39.1 2.16 t (7.6)
3 27.7 1.61 m
4 30.9 1.34 m
5 30.6 1.34 m
6 26.6 1.35 m
7 38.2 1.53 m
8 72.7 4.18 q (6.3)
9 148.7 6.24 dd (15.2, 5.8)
10 128.9 6.42 dd (15.2, 10.8)
11 144.6 7.27 dd (15.6, 10.8)
12 130.5 6.18 d (15.6)
13 204.0
14 41.2 2.61 t (7.4)
15 25.4 1.60 m
16 32.7 1.31 m
17 23.7 1.34 m
3.3. Bdelloid Rotifer Assays
3.3.1. Model Animal
The culturing, harvesting, and monitoring methods of Philodina acuticornis (PA; bdelloid rotifer)
have been reported in detail in our prior publication [17]. In brief, the animals were cultured in
standard medium (SM), a supervised and semi-sterile environment. Clear cultures of PA were kept in
standardized cell culturing flasks (cat. no.: 83.3910.302, Sarstedt AG & Co., Nümbrecht, Germany) at
25 ◦C and under a light/dark cycle of 12:12 h. Rotifers were chosen approximately 5 days after hatching
(determined by body size; length 220 ± 10 µm and width 60 ± 5 µm), 1–2 days before the beginning of
the reproductive stage.
3.3.2. Treatment Protocol
As the methodical protocols have been previously reported [17,25], only an overview of the
applied techniques is given. After 24 h of the standard isolation process, the rotifers were treated
in a 96 well plate (cat. no.: 3695, Costar, Corning Inc., Corning, NY, USA), n = 12/well/compounds.
Starting rotifer numbers per well: 25 ± 5. For this in vivo experiment, stock solutions were prepared
with 1% aqueous DMSO. The stock solutions were added to SM reaching 100 µM final concentrations
for the compounds and 0.1% DMSO content. The untreated control group (UC) was grown in SM,
while the control group (C) was kept in SM containing 0.1% DMSO (n = 12, well, respectively). The
status of the specimens under treatment was compared to the group C. This period lasted for 72 h
without feeding (toxicity interval), or feeding with homogenized yeast solution (50 µg/mL), which is
enough for survival but ceases reproduction. The viability of rotifers was assessed with three different
assays, utilizing video recordings with a Nikon D5500 DSLR camera (Nikon Corp., Japan).
3.3.3. Viability Assays
The impact of the test compounds on the lifespan of rotifers was assessed. The morphological
viability markers chosen for evaluation were defined in our previous work [17].
Toxicity and Survival Lifespan (TSL) Assay. The TSL index is a life-conditional marker of rotifers’
existence, provides mortality rate (with or without feeding).
Mastax Contraction Frequency (MCF) Assay. The mastax (pharynx) is part of the digestive system.
The function of the mastax is to shred the food by periodic opening and closing. To evaluate the viability
of rotifers in our experiments, we used the MCF (contraction/sec) as a quantitative viability marker.
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3.3.4. Statistics
Data are presented as means ± SEM. Statistical evaluation was performed with GraphPad Prism
7.0b, using One-way ANOVA with post hoc Bonferroni test. Different levels of significance are indicated
as follows: p ** ≤ 0.01, p *** ≤ 0.001 and p **** ≤ 0.0001.
3.3.5. Ethical Approval
Our experiments were performed on micro-invertebrates; therefore, according to the current
ethical regulations, no specific ethical permission was needed. The investigations were carried out
in accordance with globally accepted norms: Animals (Scientific Procedures) Act, 1986, associated
guidelines, EU Directive 2010/63/EU for animal experiments, and the National Institutes of Health
guide for the care and use of Laboratory Animals (NIH Publications No. 8023, revised 1978). Our
animal studies comply with the ARRIVE guidelines.
4. Conclusions
Our current study provides the most comprehensive chemical analysis of the mushroom
H. lateritium, affording not only novel information on the characteristic secondary metabolites of this
species, but also valuable results of in vivo toxicity assays of isolated compounds, which can present
an essential basis for future pharmacological experiments.
Supplementary Materials: Supplementary materials are available online: Figures S1–S39, Tables S1–S3.
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A B S T R A C T
In the current study effects of fungal extracts on the G-protein-activated inwardly rectifying potassium channel
(GIRK1/4) were screened using the automated patch-clamp method. 40 organic (n-hexane, chloroform, and 50%
methanol) and aqueous extracts were prepared from 10 mushroom species native to Hungary. Among the ex-
amined fungal fractions of different polarities some n-hexane and chloroform extracts exerted considerable ion
channel activity. One of the most active fungal species, Hypholoma lateritium was selected for further detailed
examination to determine the compounds responsible for the observed pharmacological property. Evaluation of
the ion channel activity of mushroom metabolites 1–10 revealed that lanosta-7,9(11)-diene-12β,21α-epoxy-
2α,3β,24β,25-tetraol (5) demonstrates remarkable blocking activity on GIRK current (IC50 395.1 ± 31.8 nM).
Investigation of the selectivity of the GIRK inhibitory effect proved that lanosta-7,9(11)-diene-12β,21α-epoxy-
2α,3β,24β,25-tetraol (5) has only weak inhibitory activity on hERG channel (7.9 ± 2.8% at 100 μM), exerting
more than three orders of magnitude lower blocking activity on hERG channel than on GIRK channel.
1. Introduction
Atrial fibrillation (AF) is a supraventricular tachyarrhythmia with
uncoordinated atrial activation and, accordingly, ineffective atrial
contraction. AF is the most common cardiac rhythm disturbance in
adults and the prevalence of this arrhythmia increases sharply with
advancing age. AF is potentially associated with life-threatening car-
diovascular conditions such as thromboembolism, stroke and heart
failure, consequently results in significant morbidity and mortality [1].
Even though the underlying mechanisms of AF is not yet entirely
understood, the cardiac acetylcholine-activated potassium ion channel
(IKACh) is considered a novel and attractive target for drug therapy in
the treatment of AF [2]. This ion channel is member of the G-protein-
coupled inwardly rectifying potassium channel (GIRK) superfamily and
is composed of GIRK1/4 (Kir3.1 and Kir3.4) subunits [3]. It has been
described that GIRK1/4 is constitutively active in myocytes from pa-
tients with chronic AF or from dog model of atrial tachycardia, and,
furthermore, these studies have demonstrated spontaneous openings of
these channels in myocytes from chronic AF patients [2,4,5]. Potent
selective inhibitors of GIRK, tertiapin and NIP-151 terminated AF, and
favorably prolonged the atrial effective refractory period in canine AF
model [6,7]. Taking all these findings together, constitutively active
GIRK channels in the atrium elevate proarrhythmic risk by causing
dispersion of atrial repolarization and refractoriness, therefore, a se-
lective GIRK blocker without affecting ventricular repolarization is ef-
fective and might be useful for the treatment of patients with AF.
A selective atrial target is extremely important. GIRK1 and GIRK4
subunits are abundant in atrium, but expressed in very small amounts
in ventricle [8,9]. However, many of drugs exert their arrhythmogenic
side effects through the ion channel encoded by the human ether-a-go-
go-related gene (hERG, Kv11.1), expressed in cardiac ventricular
myocytes, which has shown to be extremely promiscuous in its inter-
actions with a wide range of structurally unrelated molecules such as
psychiatric, antimicrobial, antihistamine, and even antiarrhythmic
drugs [1,10]. hERG represents the α-subunit of the ion channel re-
sponsible for rapid delayed rectifier potassium current (IKr) [11,12].
The IKr current plays a fundamental role in the phase 3 of repolarization
of the action potential; therefore, inhibition of hERG channel delays
cardiac action potential repolarization, which lengthens the action
potential duration (APD). Prolongation of ventricular action potential
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duration might be associated with an increased risk of the polymorphic
ventricular tachycardia Torsades de Pointes, which can degenerate into
ventricular fibrillation and sudden cardiac death [13–15]. In the past,
several drugs have been withdrawn from major markets because of
their proarrhythmic effect. At present, to avoid severe cardiotoxicity,
every new compound must go through preclinical safety testing de-
termined by the U. S. Food and Drug Administration, the European
Medicines Agency and other regulatory entities [16].
The popular term mushroom is applied for macrofungi with dis-
tinctive fruiting bodies observable to the naked eye. The number of
different mushroom species is estimated to be 140,000, of which only
10% are known to science. They have long been recognized for their
therapeutic values, particularly in traditional medicines of Far-Eastern
countries. Mushrooms are valuable sources of biologically active com-
pounds possessing antibacterial, anticancer and immunmodulatory
properties [17,18]. Extended investigation of active substances origi-
nated from mushrooms in different screening systems may result in
further discoveries of valuable new compounds.
In the present study, the effects of basidiomycetes mushroom ex-
tracts on the G-protein-activated inwardly rectifying potassium channel
(GIRK1/4) were investigated using the automated patch-clamp method.
For this purpose organic and aqueous extracts were prepared from 10
different mushrooms native to Hungary. The extracts of different po-
larities were investigated in the cell-based GIRK channel inhibitory
assay on HEK-GIRK cell line. One of the most active species was selected
for further detailed chemical examination to determine its biologically
active metabolites. The GIRK channel modulatory activities of the iso-
lated compounds were also evaluated, with the aim of discovering new
promising blockers of the GIRK1/4 channel. In addition, the most po-
tent blocker of GIRK proteins was further tested for its hERG-related
cardiotoxicity with automated patch-clamp technology on HEK-hERG
cell line.
Fig. 1. Blocking effects of fraction B of Hypholoma
lateritium on GIRK current. Panel A shows typical
current curves which were recorded during applica-
tion of fraction B of H. lateritium at 0.01mg/mL and
0.1mg/mL concentrations. Inset shows the applied
GIRK voltage protocol. Time course of calculated
inward currents from the −140mV segment of the
current sweeps is presented on panel B.
Table 1
Information on fungal species collected.
Family Species English name Habitat
Entolomataceae Rhodocybe popinalis (Fr.) Singer Not known Mixed woodland
Fomitopsidaceae Laetiporus sulphureus (Bull.) Murrill Chicken-of-the-woods Mixed woodland
Marasmiaceae Megacollybia platyphylla (Pers.) Kotl. & Pouzar Whitelaced shank Mixed woodland
Omphalotaceae Gymnopus dryophilus (Bull.) Murrill Russet toughshanks Mixed woodland
Gymnopus fusipes (Bull.) Gray Spindleshank Quercus sp. (parasitic)
Strophariaceae Hebeloma sacchariolens Quél. Sweet poisonpie Mixed woodland
Hypholoma fasciculare (Huds.) P. Kumm. Sulfur tuft Mixed woodland
Hypholoma lateritium (Schaeff.) P. Kumm. Brick tuft Mixed woodland
Tricholomataceae Tricholoma populinum J.E. Lange Cottonwood mushroom Populus sp. (mycorrhizal)
Tricholomopsis rutilans (Schaeff.) Singer Plums and custard Pinus sp. (saprobic)
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2. Materials and methods
2.1. Samples
Mushroom samples were collected in Hungary in 2012 by A.
Ványolós and members of Mushroom Society of Miskolc and of
Mushroom Society of Zemplén (Hungary). The collected species were
identified by J. Béres (Mushroom Society of Miskolc), J. Kőszeginé Tóth
(Mushroom Society of Zemplén) and A. Ványolós. Representative vou-
cher specimens (No. IC 1–10) have been deposited in the Department of
Pharmacognosy, University of Szeged. The samples were stored at
−20 °C until processing.
2.2. Sample preparation
The sporocarps of collected mushrooms were freeze-dried and
ground. Each freeze-dried sample (10 g) was extracted with 3×100mL
methanol by ultrasonication for 3×15. After filtration, the solutions
were evaporated under reduced pressure. The residues were dissolved
in 50mL of 50% aqueous MeOH and were subjected to solvent-solvent
partition between n-hexane (4×25mL) (extract A) and CHCl3
(4× 25mL) (extract B) and the residue gave extract C. After extraction
with MeOH, the residual mushroom materials were dried and extracted
with 50mL of boiling water for 15min. The filtered extracts were
freeze-dried, providing extract D.
Isolation, structure determination and characterization of com-
pounds 1–10 are described elsewhere [19].
2.3. Automated planar patch-clamp measurements
GIRK and hERG ion currents were measured using planar patch-
clamp technology in the whole-cell configuration with a four channel
medium throughput fully automated patch-clamp system (Patchliner,
Nanion Technologies GmbH, Munich, Germany; [20]. The pipetting
protocols were controlled by PatchControlHT 1.09.30 software (Nanion
Technologies GmbH., Munich, Germany). Data acquisition and online
analysis were performed with an EPC-10 Quadro patch-clamp amplifier
(HEKA Elektronik Dr. Schulze GmbH, Lambrecht/Pfalz, Germany),
using PatchMaster 2.65 software (HEKA Elektronik Dr. Schulze GmbH,
Lambrecht/Pfalz, Germany). Currents were low-pass filtered at 2.9 kHz
using the internal Bessel filter of the amplifier and digitized at 10 kHz.
Automated patch-clamp experiments were carried out at room
temperature on suspension of stable transfected cell lines. Suspension of
cells for measurements was derived from running cell culture. Cells
were maintained in incubator at 37 °C, in 5% CO2. Before experiments,
cells were washed twice with PBS (Thermo Fisher Scientific Inc.,
Waltham, USA) and then detached with trypsin-EDTA (PAN-Biotech
GmbH, Aidenbach, Germany) for 1–3min. Trypsin was blocked with
serum-containing media. The cell suspension was next centrifuged
(2min, 100 g), resuspended in serum-free media at a final density of
Table 2
Yields and blocking effects of mushroom extracts at 0.01mg/mL and 0.1mg/mL concentrations on GIRK ion channels (n=2–3).
Species Solvent Yield (w/w%) Inhibition % SEM 0.1mg/mL
0.01mg/mL 0.1 mg/mL 0.01mg/mL
Gymnopus dryophilus A 1.1 28 72 0 3
B 0.9 35 80 5 4
C 7.5 10 15 1 2
D 5.2 10 20 5 4
Gymnopus fusipes A 2.8 29 74 4 8
B 1.3 30 76 6 0
C 18.3 6 11 1 1
D 4.1 21 30 1 1
Hebeloma sacchariolens A 1.7 33 67 4 5
B 1.6 37 74 2 1
C 8.2 6 28 3 2
D 1.6 20 37 6 3
Hypholoma fasciculare A 1.6 23 53 1 4
B 3.4 25 60 6 9
C 7.2 16 35 6 3
D 4.0 12 20 4 6
Hypholoma lateritium A 2.2 33 69 3 1
B 1.0 53 79 2 1
C 16.4 25 46 0 2
D 3.9 8 14 6 3
Laetiporus sulphureus A 1.3 34 74 6 8
B 0.7 28 68 6 13
C 5.8 25 43 6 11
D 3.6 11 24 1 7
Megacollybia platyphylla A 0.9 39 61 3 15
B 0.5 29 68 6 3
C 13.0 11 11 4 6
D 6.2 8 20 0 6
Rhodocybe popinalis A 1.4 19 55 3 3
B 0.8 10 23 3 5
C 8.8 12 16 1 2
D 6.2 7 16 1 0
Tricholoma populinum A 6.0 5 25 0 4
B 1.7 41 90 2 1
C 15.0 9 17 1 16
D 4.6 17 20 3 12
Tricholomopsis rutilans A 1.3 16 52 4 3
B 2.7 37 65 4 12
C 11.5 15 31 8 11
D 1.3 12 17 0 3
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1× 106–5×106 cells/mL, and kept in the cell hotel of the Patchliner.
Cells were recovered after 15–30min and remained suitable for auto-
mated patch-clamp recordings for up to 4 h.
Stock of extra- and intracellular solutions were made for automated
patch-clamp recordings. Chemicals were purchased from Sigma-Aldrich
Corporation (St. Louis, USA). All solutions were sterile filtered. Aliquots
were stored at −20 °C and warmed up to room temperature before use.
Effects of fungal extracts and compounds isolated from Hypholoma
lateritium were tested. A stock solution of test material was prepared in
each case. The concentrations of the examined substances in the stock
solutions were 50mg of dried material/mL for the mushrooms extract
and 10mM for compounds 1–10. The solubilizing agent was dimethyl
sulphoxide (DMSO, Sigma-Aldrich Corporation, St. Louis, USA) in all
cases. Aliquots were stored at −20 °C. Before experiments, stock solu-
tions were further diluted with high K+ external solution (GIRK assay)
or external solution (hERG assay) to give appropriate concentrations for
the measurements. The final DMSO concentrations in the tested sam-
ples were 1% or less.
2.3.1. GIRK channel inhibitory assay
Experiments were carried out on HEK-293 (human embryonic
kidney) cells stably expressing the GIRK1/4 (Kir3.1/3.4) K+ channels
by adapting a method described earlier [21]. Cell line originated from
UCL Business Plc. (London, Great Britain). Cells were maintained in
DMEM (Thermo Fisher Scientific Inc., Waltham, USA) medium sup-
plemented with 10% FBS (PAN-Biotech GmbH, Aidenbach, Germany)
and 182 μg/mL zeocin (Thermo Fisher Scientific Inc., Waltham, USA).
The following solutions were used during patch-clamp recordings
(compositions in mM): external solution: NaCl 140, KCl 4, glucose-
monohydrate 5, MgCl2 1, CaCl2 3 and HEPES 10 (pH 7.4, NaOH); high
K+ external solution: NaCl 135, KCl 25, MgCl2 1, CaCl2 3 and HEPES 10
(pH 7.4, NaOH); K+-free external solution: NaCl 160, MgCl2 1, CaCl2 3
and HEPES 10 (pH 7.4, NaOH); internal solution: K-gluconate 40, NaCl
20, KF 60, EGTA 20 and HEPES 10 (pH 7.2, KOH), supplemented with
0.9 mM GTPγS before the experiments to induce channel activation.
The voltage protocol for GIRK ion channel assay (see inset on Panel
Fig. 2. Triterpenes (1−10) from Hypholoma lateritium.
Table 3
GIRK channel inhibitory activity of isolated compounds of Hypholoma lateritium
at 1 μM and 10 μM concentrations (n=2–3).
Compound inhibition % SEM
1 μM 10 μM 1 μM 10 μM
1 13 23 2 8
2 11 23 2 3
3 10 10 4 7
4 10 27 1 2
5 27 60 5 11
6 11 23 3 1
7 14 24 1 5
8 10 19 1 1
9 8 16 1 6
10 7 13 1 6
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A, Figs. 1, 3 and 4) started with a depolarizing voltage step to 60mV for
100ms before a 500ms long hyperpolarizing ramp to −140mV was
applied. Then the membrane potential remained at −140mV for
100ms before returning to the holding potential of −40mV. The in-
ward currents were calculated from the −140mV segment. The pulse
frequency was approximately 0.1 Hz.
At the beginning of recordings, the normal external solution
(4mMK+) was replaced to high K+ (25mMK+) external solution in
order to increase the current amplitude. After 2–3min of control
period, the test compounds were added to the cells in increasing con-
centrations, each for approximately 3min. Propafenone (1 μM, Sigma-
Aldrich Corporation, St. Louis, USA) was used as a reference compound.
In preliminary studies, we measured that the positive control propafe-
none exerted its effect with 373.0 ± 27.7 nM IC50 value and at 1 μM
concentration inhibited the GIRK current by 71.4 ± 4.6% (n=6).
Finally, potassium free external solution was applied to completely
cease inward potassium currents. The data were corrected with the
current values measured in the potassium free external solution, which
served as the baseline.
2.3.2. hERG channel inhibitory assay
hERG measurements were performed on HEK-293 cells stably
transfected with cDNA encoding the hERG (Kv11.1) K+ channel as
described earlier in detail [21,22]. Cell line was purchased from Cell
Culture Service (Hamburg, Germany). Cells were maintained in IMDM
(PAN-Biotech GmbH, Aidenbach, Germany) medium supplemented
with 10% FBS (PAN-Biotech GmbH, Aidenbach, Germany), 2 mM L-
glutamine (PAN-Biotech GmbH, Aidenbach, Germany), 1 mM Na-pyr-
uvate (PAN-Biotech GmbH, Aidenbach, Germany) and 500 μg/mL G418
(Thermo Fisher Scientific Inc., Waltham, USA).
The following solutions were used during patch-clamp experiments
(compositions in mM): external solution: NaCl 140, KCl 4, glucose-
monohydrate 5, MgCl2 1, CaCl2 3 and HEPES 10 (pH 7.4, NaOH); in-
ternal solution: KCl 50, NaCl 10, KF 60, EGTA 20 and HEPES 10
(pH 7.2, KOH).
The voltage protocol for hERG ion channel (see inset on Panel A,
Fig. 5) started with a short (100ms) –40mV step to establish the
baseline region. A depolarizing step was applied to the test potential of
20mV for 3 s, and then the cell was repolarized to −40mV (1 s) to
evoke outward tail current. Holding potential was −80mV. The pulse
frequency was approximately 0.1 Hz. The peak tail current was cor-
rected the leak current defined during the first period to −40mV.
Recording started in external solution. After this control period, the
test compound was applied for approximately 3min. Following the test
compound, 10 μM amitriptyline was used as a reference inhibitor then a
wash-out step terminated the pipetting protocol.
2.4. Statistics
All data are expressed as arithmetic means± standard error (SEM).
Statistical analysis was performed with Student's t-test for paired data,
and corrected using the Holm-Bonferroni method. Differences were
considered statistically significant when P value was< 0.05.
3. Results and discussion
Initially, as part of the screening study the GIRK channel inhibitory
effects of some mushroom extracts obtained from species native to
Hungary were evaluated. Extracts were examined at two concentrations
(0.01mg/mL and 0.1mg/mL) on two to three cells. Totally, 40 extracts
of 10 higher basidiomycete mushrooms (see Table 1) were assessed:
Gymnopus dryophilus, Laetiporus sulphureus, and Tricholoma populinum
Fig. 3. Blocking effects of compound 5 on GIRK
current. Panel A depicts original current sweeps
which were recorded during application of com-
pound 5 at 1 μM, 3 μM, 10 μM and 30 μM con-
centrations. Inset shows the applied GIRK voltage
protocol. Time course of calculated inward currents
from the −140mV segment of the current curves is
presented on panel B.
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are edible; Gymnopus fusipes, Hypholoma lateritium, Megacollybia platy-
phylla, Rhodocybe popinalis and Tricholomopsis rutilans are either not
recommended for consumption or there are conflicting reports on their
edibility; while Hebeloma sacchariolens and Hypholoma fasciculare are
poisonous species. To the extent of our knowledge no other study has
previously investigated the potential GIRK channel activity of mush-
rooms. According to the results obtained some fungal species display
notable inhibitory activity on GIRK channel. G. dryophilus and G. fusipes
are related mushrooms, which have not been extensively studied, the
former contains a water-soluble polysaccharide, which has a potential
immunomodulatory property based on the inhibition of NO production
[23,24]; the latter is a parasitic, root-decay fungus, which has been
recently identified as a source of unique cyclic octadecapeptides. [25].
Very little is known about the chemistry of H. sacchariolens, a small
mushroom with a bitter taste, but a sweet and flowery smell. According
to Wood et al., the source of the specific, pleasant odor is 2-amino-
benzaldehyde [26]. H. lateritium, brick cap by its vernacular name, is a
fairly popular edible mushroom in Japan, Korea and the United States,
but in Europe it is considered inedible. Compared to its more common
relative, the poisonous sulfur tuft (H. fasciculare), the chemistry and
Fig. 4. Inhibitory effects of compound 5 on GIRK current. Panel A displays representative current curves which were recorded during application of compound 5 at
0.1 μM, 0.3 μM, 1 μM and 3 μM concentrations. Inset shows the applied GIRK voltage protocol. Time course of calculated inward currents from the −140mV segment
of the current curves is presented on panel B. Panel C shows the dose-response curves of compound 5. The GIRK channel inhibitory activity of compound 5 could be
characterized by the relative IC50 value of 395.1 ± 31.8 nM (n=5).
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pharmacology of H. lateritium are explored in a weaker extent. This
species was found to produce several triterpenes e.g. fasciculols, fasci-
culic acids and sublateriols as well as sesquiterpenes eg. naematolin, a
caryophyllane derivative with cytotoxic activity [27–29].
L. sulphureus, commonly known as sulphure polypore, is a delicious
bracket fungus, growing on dead or living trees. It has a vast scientific
literature, many of its chemical constituents (polysaccharides, tri-
terpenes, polyene pigments) have been described [30–32], possessing a
variety of pharmacological properties (anticancer, antimicrobial, anti-
oxidant and hypoglycemic) [31,33,34]. T. populinum - also known as
cottonwood mushroom - is a mycorrhizal fungus with lower culinary
value which produces ergostane type steroids and methylsulfinylade-
nosine derivatives [35].
Among the fractions with different polarities, fraction A (n-hexane
fractions with the more lipophilic constituents) and fraction B (CHCl3-
soluble compounds) proved to be active (i. e., at least 50% decrease in
the current at 0.1 mg/mL concentration). The aqueous (fraction D) and
aqueous MeOH (fraction C) extracts did not demonstrate considerable
activity on GIRK channel (< 40% decrease in the current at 0.1 mg/mL)
(see Table 2.)
However, there are some exceptions: neither fraction B of R. popi-
nalis nor fraction A of T. populinum exerted remarkable blocking effect
on the GIRK channel, whereas fractions C of L. sulphureus and H. la-
teritium proved to have notable inhibitory activities.
Fraction B of H. lateritium proved to be the most effective (53%
decrease on GIRK current) at the lower (0.01mg/mL) concentration
among the tested fungal extracts (Fig. 1).
Therefore, this species was chosen for in-depth chemical analysis in
order to identify the secondary metabolites responsible for the observed
ion channel activity. Thanks to combined chromatographic techniques
we have previously identified a series of triterpenes (see Fig. 2):
fasciculic acid B (1), fasciculol E (2), fasciculol C (3), fasciculol F (4),
lanosta-7,9(11)-diene-12β,21α-epoxy-2α,3β,24β,25-tetraol (5), de-
methylincisterol A2 (6), and 3β-O-glucopyranosyl-5,8-epidioxyergosta-
6,22-diene (7), ergosterol (8), 3β-hydroxyergosta-7,22-diene (9), and
cerevisterol (10) [19].
The fungal metabolites were involved in the GIRK channel in-
hibitory assay at 1 μM and 10 μM concentrations. Compounds were
tested on two to three cells (Table 3).
Most of the isolated metabolites possessed moderate activity on
GIRK channel except compound 5, which found to be an active in-
hibitor of GIRK channel. Therefore, the dose-response curve and IC50
value of 5 were characterized in detailed experiments where its effect
was tested in 4 concentrations on 5 cells. Initially, investigations were
performed at 1 μM, 3 μM, 10 μM and 30 μM concentrations. GIRK cur-
rent was considerably reduced by these concentrations; the effects on
the inward current were statistically significant in all tested con-
centrations. Application of compound 5 at 1 μM concentration inhibited
the GIRK current by 42.0 ± 6.4%. Elevation of the concentration of 5
to 3 μM and to 10 μM resulted in further decrease in GIRK current
(60.8 ± 5.0% and 66.4 ± 4.5% inhibitions, respectively). Further
increase in test compound level did not alter the current (66.7 ± 4.6%
inhibition at 30 μM). Consequently, the maximum effect was de-
termined to this value, and, presumably, the drug may only inhibit
66.7% of the current even at the highest doses (Emax= 0.6675).
Original GIRK current curves and the time course of decrease in the
current are shown on Fig. 3. Compound 5 was also tested in detailed
experiments on GIRK cell line at 0.1 μM, 0.3 μM, 1 μM and 3 μM con-
centrations, in order to acquire the complete dose-response curve. GIRK
current was considerably reduced by compound 5 in concentration-
dependent manner. The relative IC50 value (the concentration corre-
sponding to a response midway between the estimates of the lower and
Fig. 5. Effects of compound 5 on hERG current.
Panel A presents typical hERG current sweeps during
the application of 100 μM compound 5. The inset
shows the applied hERG voltage protocol. The ori-
ginal current traces reveal that 5 slightly blocked the
hERG channel, while addition of reference com-
pound amitriptyline (10 μM) fully blocked the cur-
rent. Time course of decrease in the peak tail current
are presented on panel B.
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upper plateaus of the dose-response curve, i.e., 0% and 66.7% inhibi-
tion) was determined to be 395.1 ± 31.8 nM (Fig. 4) [36].
Compound 5 was also tested on HEK-hERG cell line and selectivity
of their GIRK blocking effect was evaluated with these experiments.
Selectivity study was performed at 100 μM concentration on 12 cells.
Compound 5 exhibited only slight inhibitory activity (7.9 ± 2.8%) on
hERG channel even at this high concentration, showing more than three
orders of magnitude higher blocking activity on GIRK channel com-
pared to the results obtained on hERG channel. Original hERG current
sweeps during the application of compound 5 at 100 μM concentration
and the time course of decrease in the peak tail current are shown on
Fig. 5.
Atrial fibrillation (AF) is the most common serious abnormal heart
rhythm. In the last two decades, AF has become a very important public
health issue, and responsible for huge and rapidly growing healthcare
expenditures in Western countries [1,37]. AF is present in
0.12%–0.16% of those younger than 49 years, in 3.7%–4.2% of those
aged 60–70 years, and in 10%–17% of those aged 80 years or older
[37].> 750,000 hospitalizations happen because of AF, and it con-
tributes to an estimated 130,000 deaths each year just in the U.S. [38].
Current antiarrhythmic drugs have numerous disadvantages, particu-
larly the lack of atrial selectivity associated with an increased risk of
side effects especially proarrhythmia and the poor efficacy rate (e.g.,
50–60% for amiodarone, which is generally considered as the most
effective drug). With this background, more targeted approaches are
required to improve therapy of AF [1,39].
Exploiting the potential biological activity of macrofungi, extracts of
basidiomycete mushrooms were investigated in our GIRK screen
system, with the aim to identify natural sources of promising ion
channel blocking compounds. Extracts of different polarity were
screened, and one of the most active species, H. lateritium was further
investigated for active compounds. Among fungal metabolites 1–10,
compound 5 demonstrated notable blocking activity on GIRK current.
Considering its intense blocking effect and high selectivity, 5 is a po-
tential promising agent in treatment of AF, despite no complete in-
hibition was observed. The current study unambiguously confirms that
higher macrofungi deserve special attention in terms of secondary
metabolites with valuable pharmacological properties.
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Hypholoma lateritium is an edible macrofungus with a common distribution in Europe, North America, and
the Far East. The aim of this study was to investigate the potential anti-inflammatory effects of H. lateritium
extracts and its isolated steroids: fasciculic acid B, fasciculol E, fasciculol C, lanosta-7,9(11)-diene-12β,21α-epoxy-
2α,3β,24β,25-tetraol, fasciculol F, and demethylincisterol A2. Organic (hexane, chloroform and 50% methanol)
and water extracts of H. lateritium were subjected to in vitro assays to determine pro-inflammatory protein levels,
such as cyclooxygenase-2 (COX-2), cytosolic prostaglandin E2 synthase (cPGES), and antioxidant nuclear factor
(erythroid-derived 2)-like 2 (Nrf2). Fungal extracts demonstrated significant activities on pro-inflammatory protein
levels with minor differences among the activities of the fractions of different polarities. All the compounds
proved to exert notable inhibitory properties on COX-2 and were capable to stimulate the Nrf2 pathway. Fungal
extracts and the compounds exerted no cytotoxic activities on RAW 264.7 cells.
Keywords: Hypholoma lateritium, steroids, anti-inflammatory activity, COX-2, Nrf2.
Introduction
The genus Hypholoma, which means ‘mushrooms with
threads’, belongs to the family Strophariaceae and
includes mushroom species possessing characteristic
well-pigmented pileus and variably developed thread-
like veil, which does not form a membranous annulus
on the stipe.[1] The genus consists of about 30 species
worldwide, occurring in temperate to tropical regions,
growing on decomposing wood, living trees, or soil.[2]
Hypholoma species are recognized as active wood and
litter decomposers and play a significant role in forest
ecosystems, being used not only in bioconversion of
cellulose, fabric and dye industrial residues,[3,4] but also
in biological control of phytopathogenic fungi.[5,6]
Hypholoma fasciculare is the most widespread and
investigated member of the genus, which is known for
its antioxidant and antimicrobial activities,[7] producing
different types of fungal metabolites, e.g., styrylpyr-
one-type compounds (hypholomins, fasciculins),[8] ste-
roids (fasciculic acids, fasciculols),[9,10] and sesquiterpe-
noids (fascicularones).[11,12]
Apart from H. fasciculare, there is H. lateritium (brick
cap mushroom), a less known related species, but still
with a quite common distribution in Europe, North-
America and the Far East. It is a saprobic macrofungus,
occurring regularly in small tufts or sometimes singly
on hardwood stumps and exposed roots of dead
hardwood trees. H. lateritium was reported to contain
DOI: 10.1002/cbdv.202000391 FULL PAPER
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steroid compounds, e.g., fasciculols, fasciculic acids
and sublateriols[13,14] as well as sesquiterpenes, e.g.,
naematolin, a caryophyllane derivative with antiproli-
ferative property.[15] We have recently explored the
chemistry of this species and identified a series of
steroids with remarkable structural diversity including
ergostane and lanostane derivatives, along with highly
degraded sterols with ion channel modulating
properties.[16,17]
As regard the pharmacology of H. lateritium,
previous investigations revealed that this species
possesses considerable biological properties; however,
these experiments were performed with crude extracts
without identifying the major fungal metabolites
responsible for the observed biological activity. Lee at
al. demonstrated that the extract of this species
decreases TNF-α-induced inflammation in human
umbilical vein endothelial cells. The butanol fraction of
H. lateritium inhibited TNF-α-induced monocyte adhe-
sion to endothelial cells; moreover, it dose-depend-
ently decreased the expression of inducible nitrogen
oxygen synthase and cyclooxygenase-2.[18] In another
article, Lee et al. investigated the inhibitory effect of H.
lateritium extract on highly invasive and metastatic
tumor cells. The hexane fraction of brick cap signifi-
cantly inhibited the invasion and migration of MDA-
MB-231 breast cancer cells in the Matrigel invasion
assay and wound-healing investigations, respectively.
The results obtained suggested that hexane extract of
H. lateritium inhibits the metastatic potential of MDA-
MB-231 cells by inhibiting the phosphorylation of JNK/
p38 and reducing AP-1 and NF-кB DNA-binding
activities.[19]
Despite of its wide geographical distribution and
richness in various fungal metabolites with pharmaco-
logical potential, the ethnomycological profile of H.
lateritium is rather unexplored. Nonetheless, this
mushroom was used in Swedish folk medicine as an
anti-inflammatory agent in alleviating symptoms of
rheumatic disorder.[20] Therefore, we conducted a
research to explore the anti-inflammatory properties
of H. lateritium extracts and its characteristic constitu-
ents, fasciculic acid B (1), fasciculol E (2), fasciculol C
(3), lanosta-7,9(11)-diene-12β,21α-epoxy-2α,3β,24β,25-
tetraol (4), fasciculol F (5), and demethylincisterol A2
(6) for the purpose of confirming the traditional use of
this species.
Results and Discussion
Basidiomycota mushrooms are known to possess
various beneficial pharmacological properties includ-
ing anti-inflammatory activity.[21] Previous studies
revealed that several extracts prepared from certain
edible mushrooms have anti-inflammatory potential:
Cantharellus cibarius,[22] Imleria badia,[23] and Agaricus
bisporus.[24] In the current study, we examined the pro-
or anti-inflammatory properties of H. lateritium extracts
and identified specific fungal metabolites (1–6) which
may contribute to the favorable biological activities of
this fungal species. Accordingly, organic (hexane,
chloroform and 50% methanol) and H2O extracts of H.
lateritium were prepared, and then, they were sub-
jected to in vitro tests in order to determine the pro-
inflammatory protein levels, such as COX-2, cPGES as
well as Nrf2 using Western blot techniques. Regarding
the cytotoxic effect, no such activities were observed
in RAW 264.7 cells incubated with mushroom extracts
and fungal metabolites 1–6. Cell viabilities were
around 100% after treatment. According to results, all
fractions demonstrated significant biological activities
in the assays performed, however, minor differences
were observed among the activities of the fractions
with different polarities (Figure 1).
In RAW 264.7 cells activated with LPS and incu-
bated with mushroom extracts A–D, an increase of
Nrf2 was observed. In the same way, higher levels of
cPGES protein were detected in macrophages co-
treated with LPS and extracts A–D, but the values
obtained were significantly lower compared to those
of the LPS-activated cells. The investigations revealed
a decrease in COX-2-levels in RAW 264.7 cells co-
treated with mushrooms extracts and LPS in compar-
ison with the experiment of LPS-activated macro-
phages.
To identify the main constituents of H. lateritium
responsible for the detected anti-inflammatory proper-
ties of the crude fungal extracts, we proposed to
perform the pharmacological assay of characteristic
compounds of H. lateritium. The fungal metabolites
investigated in the current study belong to the vast
class of steroids (Figure 2).
Fasciculic acid B (1), fasciculol E (2), fasciculol C (3),
and fasciculol F (5) represent a special group of
compounds known as fasciculols which are specific to
mushrooms of the Hypholoma genus, especially H.
fasciculare and H. lateritium, lanosta-7,9(11)-diene-
12β,21α-epoxy-2α,3β,24β,25-tetraol (4) is a related
steroid recently identified in H. lateritium, while
demethylincisterol A2 (6) is a highly degraded sterol
Chem. Biodiversity 2020, 17, e2000391
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Figure 1. Levels of COX-2 (a), cPGES (b) and Nrf2 (c) and their representative blots (d) in RAW 264.7 cells incubated with extracts of
H. lateritium (100 μg) and activated with LPS. N=5. # vs. control, * vs. LPS, p<0.05.
Figure 2. Structures of steroids from Hypholoma lateritium.
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reported originally from a marine sponge of Homax-
inella sp.[25] Previous investigations revealed that these
compounds could have important pharmacological
properties, including the calmodulin antagonistic
activity of fasciculic acid B (1) and the cytotoxic
property of demethylincisterol A2 (6).[10,25] Our experi-
ments (Figure 3) revealed that 1–6 activated cPGES,
but levels of this protein were lower than those in LPS-
activated RAW 264.7 cells. In cells activated with LPS
and incubated with 1–6, we experienced an increase
of Nrf2. Compounds 1–6 in general proved to possess
similar activities, however, fasciculol C (3) represents a
particular case, because when cells were treated with
3 alone the amount of cPGES was the lowest, while
the level of Nrf2 was the highest among the values
obtained in all experiments.
Macrophages activated with LPS and incubated
with fungal metabolites were characterized by de-
creased COX-2 levels when compared to LPS-activated
macrophages.
Nrf2, or nuclear factor (erythroid-derived 2)-like 2, is
an essential transcription factor that controls the
expression of antioxidant proteins that protect against
oxidative damage produced by injury and inflamma-
tion. It is a key participant of cellular defense
mechanism; activation of Nrf2 leads to a subsequent
production of proteins and antioxidant enzymes,
providing the damaged cells and tissues with a
complex antioxidant defense. Plenty of studies un-
equivocally demonstrate that many plant metabolites
from fruits and vegetables, e.g., curcumin,[26]
resveratrol[27] and sulforaphane[28] are capable of
regulating Nrf2. Although many plants produce a
variety of compounds with Nrf2 activity, the potential
of mushroom metabolites in this view is largely
unexplored. However, extracts from Agaricus bisporus
mycelia enriched in α-linolenic acid presented Nrf2
modulating activity.[24] Only a few fungal compounds
are known to regulate the Nrf2 pathway, including the
benzoid type antrolone and the ubiquinone derivative
antroquinonol identified in Antrodia sp., and several
steroids from the renowned Ganoderma lucidum.[29,30]
The current study demonstrates that the examined
fungal steroids could have several beneficial pharma-
cological properties providing multiple opportunities
for the potential therapeutic application of these
secondary metabolites.
Conclusions
Organic and water extracts of H. lateritium and
compounds 1–6 proved to demonstrate not only
considerable inhibitory properties on COX-2, but they
are also capable to stimulate the Nrf2 pathway. Our
results provide experimental evidence that extracts of
Hypholoma lateritium and characteristic compounds of
the hexane (6), chloroform (1–5) and more polar (1, 3)
Figure 3. Levels of COX-2 (a), cPGES (b) and Nrf2 (c) and their representative blots (d) in RAW 264.7 cells incubated with compounds
1–6 isolated from H. lateritium (10 μg) and activated with LPS. N=5. # vs. control, * vs. LPS, p<0.05.
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fractions possess anti-inflammatory activities, which




Sporocarps of Hypholoma lateritium (Schaeff.) P. Kumm
(Strophariaceae family) were gathered in September
2015 in the vicinity of Bakonybél, Hungary. Fungal
identification was made by Attila Sándor (Hungarian
Mycological Society). A voucher specimen (No. H018)
has been deposited at the Department of Pharmacog-
nosy, University of Szeged, Szeged, Hungary.
Sample Preparation
Sporocarps of H. lateritium were lyophilized and
ground with a grinder, then, a 10 g sample was
extracted with 3×100 mL methanol for 3×15 min
using ultrasonic bath. Following filtration, the extracts
were combined and concentrated in vacuum. The
residue was dissolved in 50 mL of 50% aqueous MeOH
and was subjected to liquid  liquid partition between
hexane (4×25 mL) (extract A) and CHCl3 (4×25 mL)
(extract B) and the remaining material provided extract
C. After extraction with MeOH, the residual fungal
material was dried and extracted with 50 mL of boiling
H2O for 15 min. The filtered extract was lyophilized to
give extract D.
Isolation, identification and characterization of
fasciculic acid B (1), fasciculol E (2), fasciculol C (3),
lanosta-7,9(11)-diene-12β,21α-epoxy-2α,3β,24β,25-tet-
raol (4), fasciculol F (5), and demethylincisterol A2 (6)
have been previously performed by our research
group and are described in a publication by Chuluun-
baatar et al.[16]
Cell Cultures
Murine macrophages RAW 264.7 (TIB-71, ATCC, Manas-
sas, VA, USA) were cultured in Dulbecco’s Modified
Eagle’s Medium supplemented with 10% Fetal Bovine
Serum (FBS) and 1% solution of antibiotics (100 IU/mL
penicillin, 0.1 μg/mL streptomycin). Cells were main-
tained at 37 °C in humidified atmosphere of 5% CO2 in
air and were finally seeded into a 6-well plate (Sarstedt
AG & Co., Nümbrecht, Germany) at a density of 5×
105 cells/well in 2 mL of medium. Cell morphology was
investigated in every step of the procedure by an
inverted light microscope (Olympus, Tokyo, Japan).
Cell viability during culturing was assessed with a
Trypan Blue (Thermo Fisher Scientific, Waltham, MA,
USA) exclusion test. RAW 264.7 cells were activated
with LPS (10 ng/mL; Sigma  Aldrich, Saint Louis, MO,
USA) and incubated overnight. After that, macro-
phages were treated with mushroom extracts A–D of
H. lateritium at concentrations of 50 and 100 μg for
24 h or with the isolated compounds 1–6 (1 and
10 μg) for 24 h. Following 24 h of incubation, the cells
after scrapping were collected.
Cell Proliferation XTT Assay
Cell proliferation was evaluated using a sodium 2,3-
bis(2-methoxy-4-nitro-5-sulfophenyl)-5-
[(phenylamino)carbonyl]-2H-tetrazolium) inner salt
(XTT) with N-methyldibenzopyrazine methyl sulfate)
working as the intermediate electron carrier (PMS).
RAW 264.7 cells were seeded in 96-well plates (2.5×
103 cells/well) and incubated for 24 h. The medium
was then removed and 0.5; 1; 2.5; 5; 10; 50 and 100 μg
of mushroom extracts A–D as well as compounds 1–6
were added to FCS-free medium and incubated for the
next 24 h. Then, XTT solution (50 μL) was added to
each well and incubated for 4 h at 37 °C according to
the manufacturer instruction (Sigma  Aldrich). The
absorbance was measured at 475 nm and 630 nm in a
Omega plate reader (BMG LABTECH, San Diego, CA,
USA). The specific absorbance of the sample was
calculated as follows: Specific Absorbance=A475nm
(sample)  A475nm (blank)  A660nm (sample). Cell viability
was expressed as the percentage of control.
Western Blot for Quantity of COX-2, cPGES and Nrf2
Receptor
M-PER mammalian protein extraction reagent (Thermo
Scientific, Rockford, IL, USA) with protease inhibitor
cocktail set III (Merck, Darmstadt, Germany) was used
for cell lysates preparation. Total protein concentra-
tions were quantified using the Bradford reaction.
Forty μg of proteins per sample were solubilized in a
Laemmli buffer with 2% mercaptoethanol (BioRad,
Hercules, CA, USA) and subjected to 10% SDS-
polyacrylamide gel electrophoresis. Primary antibodies
were used: anti-cyclooxygenase-2 (COX-2), anti-β-actin
diluted 1 :1000 (Thermo Fisher Scientific), anti-prosta-
glandin E2 synthase (Cayman Chemical, Ann Arbor, MI,
USA) diluted 1 :1000, anti-Nrf2 receptor (GeneTex,
Irvine, CA, USA) diluted 1 :200 and secondary antibody
anti rabbit IgG (HRP) (Thermo Fisher Scientific,
Chem. Biodiversity 2020, 17, e2000391
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1 :2000). Proteins were determined using the Western
blotting detection kit Clarity Western ECL Luminol
Substrate (Bio-Rad, USA). The integrated optical den-
sities of the bands were measured using Chemi Doc
Camera with Image Lab software (BioRad).
Statistical Analysis
All the results are presented as means� standard
deviation (SD). The statistical analysis was carried out
using the one-way ANOVA; p<0.05 was considered to
be significant.
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